_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
717919153,5/9/2015 18:55:41,1633310957,5/9/2015 18:55:15,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,postoperative supraventricular TACHYCARDIA.,96-127-110,65,VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 18:59:09,1633312044,5/9/2015 18:58:57,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,postoperative supraventricular TACHYCARDIA.,96-110-127,47-56-65,constant infusion VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:00:33,1633312452,5/9/2015 19:00:25,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,postoperative supraventricular TACHYCARDIA.,96-110-127,47-56-65,constant infusion VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:00:36,1633312463,5/9/2015 18:59:47,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,constant - infusion verapamil postoperative supraventricular TACHYCARDIA.,47-55-56-65-96-110-127,47-55-56-65-96-110-127,constant - infusion VERAPAMIL postoperative supraventricular tachycardia.,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:16:14,1633323227,5/9/2015 19:16:04,false,clixsense,1,24763049,GBR,,,86.137.164.185,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,TACHYCARDIA.,127,65,VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:19:19,1633327300,5/9/2015 19:18:57,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,verapamil for the treatment of postoperative supraventricular TACHYCARDIA.,65-75-79-93-96-110-127-83,40-44-47-56-65-75-79-83-93-96-110-127,Use of constant infusion VERAPAMIL for the treatment of postoperative supraventricular tachycardia.,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:29:57,1633338570,5/9/2015 19:29:32,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,TACHYCARDIA.,127,65,VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:40:38,1633342846,5/9/2015 19:38:51,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,supraventricular TACHYCARDIA.,110-127,65,VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:41:43,1633343190,5/9/2015 19:41:21,false,elite,1,30064988,GBR,,,89.241.94.221,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,postoperative supraventricular TACHYCARDIA.,96-110-127,65,VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919153,5/9/2015 19:42:58,1633343617,5/9/2015 19:42:35,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,127,65,,,138,74,TACHYCARDIA,VERAPAMIL,postoperative supraventricular TACHYCARDIA.,96-110-127,47-56-65,constant infusion VERAPAMIL,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia.",127,65,127,65,-1,138,74,TWrex-cause,800609,"Iberti TJ, Benjamin E, Paluch TA et al. Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia",tachycardia,verapamil
717919154,5/9/2015 20:56:09,1633368753,5/9/2015 20:55:51,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,7,44-55-72,IDIOPATHIC THROMBOCYTOPENIC PURPURA,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/9/2015 21:30:23,1633381202,5/9/2015 21:30:08,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,"Severe THROMBOCYTOPENIA may occur,",0-7-24-28,7-24-28-35-44-55-72,"thrombocytopenia may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA","Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/9/2015 22:15:35,1633397451,5/9/2015 22:15:11,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,Severe THROMBOCYTOPENIA,0-7,44-55-72-120,IDIOPATHIC THROMBOCYTOPENIC PURPURA SLE.,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/9/2015 22:45:06,1633409351,5/9/2015 22:44:30,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,7,44-55-72,IDIOPATHIC THROMBOCYTOPENIC PURPURA,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/9/2015 23:50:30,1633438015,5/9/2015 23:50:16,false,neodev,1,31139768,USA,DE,,108.59.10.153,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,"Severe THROMBOCYTOPENIA may occur,",0-7-24-28,24-28-44-55-72,"may occur, IDIOPATHIC THROMBOCYTOPENIC PURPURA","Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/10/2015 00:19:34,1633451569,5/10/2015 00:19:23,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,Severe THROMBOCYTOPENIA,0-7,44-55-72-80,IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP),"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/10/2015 00:50:51,1633462006,5/10/2015 00:50:32,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,7,44-55-72-80,IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP),"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/10/2015 01:01:41,1633465548,5/10/2015 01:01:20,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,7,44-55-72,IDIOPATHIC THROMBOCYTOPENIC PURPURA,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/10/2015 01:54:54,1633483554,5/10/2015 01:54:34,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,7,44-55-72,IDIOPATHIC THROMBOCYTOPENIC PURPURA,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919154,5/10/2015 02:00:38,1633485462,5/10/2015 02:00:06,false,clixsense,1,22947672,GBR,,,88.144.86.217,7,44,,,23,79,THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,7,44-55-72-80,IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP),"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE.",7,44 55 72,7,44,1,23,79,TWrex-cause,814536,"Severe thrombocytopenia may occur, however; idiopathic thrombocytopenic purpura (ITP) may be an initial presentation of SLE",thrombocytopenia,idiopathic thrombocytopenic purpura
717919155,5/9/2015 19:22:06,1633331074,5/9/2015 19:21:52,false,clixsense,1,24763049,GBR,,,86.137.164.185,221,178,,,225,180,PAIN,TN,PAIN,221,178,TN,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 19:35:53,1633341054,5/9/2015 19:35:39,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,178,TN,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 19:51:34,1633346507,5/9/2015 19:51:15,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,178,TN,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 19:51:56,1633346640,5/9/2015 19:50:54,false,elite,1,30064988,GBR,,,89.241.94.221,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,178,TN,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 19:56:59,1633348213,5/9/2015 19:56:36,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,178,TN,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 20:04:05,1633350596,5/9/2015 20:03:32,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,159-162-169-178-181-186-189-204-209-221,"or facial muscles, TN must be differentiated from masticatory pain","The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 20:48:49,1633366248,5/9/2015 20:48:24,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,162-169-178,"facial muscles, TN","The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 21:16:50,1633376320,5/9/2015 21:16:32,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,178,TN,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 21:23:45,1633378928,5/9/2015 21:23:28,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,221,178,,,225,180,PAIN,TN,masticatory PAIN,209-221,178-181-186-189,TN must be differentiated,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919155,5/9/2015 21:33:37,1633382492,5/9/2015 21:32:20,false,instagc,1,31861996,USA,FL,Homestead,73.46.199.178,221,178,,,225,180,PAIN,TN,differentiated from masticatory PAIN that has the,189-204-209-221-226-231-235,159-162-169-178-181-186-189,"or facial muscles, TN must be differentiated","The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain.",221,178,221,178,1,225,180,TWrex-cause,812652,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from masticatory pain that has the clinical characteristics of deep somatic rather than neuropathic pain",pain,TN
717919156,5/9/2015 16:28:53,1633254508,5/9/2015 16:28:39,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110,PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 16:46:02,1633260630,5/9/2015 16:45:21,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110-109,PPD - S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 16:56:53,1633265689,5/9/2015 16:56:37,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-109-110,PPD - S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 16:59:34,1633266756,5/9/2015 16:58:50,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110,PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 17:06:46,1633269861,5/9/2015 17:06:24,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110,PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 17:10:32,1633271096,5/9/2015 17:09:43,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110,PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 17:12:21,1633271659,5/9/2015 17:11:47,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS in adults,43-56-59,95-98-103-106-110,TU dose of PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 17:33:40,1633280195,5/9/2015 17:33:26,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106,PPD,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 17:34:48,1633280681,5/9/2015 17:34:30,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110,PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919156,5/9/2015 17:45:32,1633284547,5/9/2015 17:44:13,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,43,106,,,55,109,TUBERCULOSIS,PPD,TUBERCULOSIS,43,106-110,PPD S,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL.,43,106,43,106,-1,55,109,TWrex-cause,803046,Diagnostic standards and classification of tuberculosis in adults and children  The standard 5-TU dose of PPD-S is the delayed skin test activity contained in a PPD-S dose of 0.1 mg/0.1 mL,tuberculosis,PPD
717919157,5/9/2015 16:20:05,1633251061,5/9/2015 16:19:57,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:25:49,1633253321,5/9/2015 16:25:34,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:30:21,1633255083,5/9/2015 16:30:12,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:36:52,1633257674,5/9/2015 16:36:15,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:51:39,1633262831,5/9/2015 16:51:18,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,TOXOPLASMOSIS,11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:53:05,1633263695,5/9/2015 16:52:48,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:57:02,1633265767,5/9/2015 16:56:48,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS is caused by transplacental acquisition of Toxoplasma gondii.,0-11-25-28-35-38-53-65-69-80,0-11-25-28-38-53-65-69-80-35,Congenital toxoplasmosis is caused by transplacental acquisition of TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 16:57:11,1633265831,5/9/2015 16:56:40,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,38-53-65-69-80,transplacental acquisition of TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 17:00:41,1633267153,5/9/2015 16:59:57,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919157,5/9/2015 17:01:59,1633267917,5/9/2015 17:01:05,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,11,69,,,24,86,TOXOPLASMOSIS,TOXOPLASMA GONDII,Congenital TOXOPLASMOSIS,0-11,69-80,TOXOPLASMA GONDII.,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii.,11,69 80,11,69,1,24,86,TWrex-cause,810695,Congenital toxoplasmosis is caused by transplacental acquisition of  Toxoplasma gondii,toxoplasmosis,toxoplasma gondii
717919158,5/9/2015 18:45:35,1633307148,5/9/2015 18:44:42,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,64,LISINOPRIL,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 18:55:15,1633310813,5/9/2015 18:54:40,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,64-75-95-101,LISINOPRIL hydrochlorothiazide fixed combinations,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 18:58:56,1633311989,5/9/2015 18:58:41,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,64,LISINOPRIL,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 18:59:45,1633312220,5/9/2015 18:59:19,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,158,64,,,170,74,HYPERTENSION,LISINOPRIL,Lisinopril hydrochlorothiazide HYPERTENSION.,64-75-158,64-75-158,LISINOPRIL hydrochlorothiazide hypertension.,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 19:00:23,1633312418,5/9/2015 19:00:04,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,61-64-75,• LISINOPRIL hydrochlorothiazide,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 19:16:03,1633322891,5/9/2015 19:15:45,false,clixsense,1,24763049,GBR,,,86.137.164.185,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,64,LISINOPRIL,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 19:18:56,1633326784,5/9/2015 19:18:22,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,158,64,,,170,74,HYPERTENSION,LISINOPRIL,Lisinopril fixed combinations should not be used for initial treatment of HYPERTENSION.,64-95-101-114-121-125-128-137-145-155-158-133,64-75-95-101-114-121-125-128-133-137-145-155-158,LISINOPRIL hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 19:29:31,1633338414,5/9/2015 19:29:17,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,64,LISINOPRIL,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 19:38:50,1633342203,5/9/2015 19:38:00,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,61-64-75,• LISINOPRIL hydrochlorothiazide,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919158,5/9/2015 19:41:20,1633343072,5/9/2015 19:40:43,false,elite,1,30064988,GBR,,,89.241.94.221,158,64,,,170,74,HYPERTENSION,LISINOPRIL,HYPERTENSION.,158,64,LISINOPRIL,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension.",158,64,158,64,-1,170,74,TWrex-cause,804115,"59 ,   60  Dosage and Administration  General  Hypertension  •  Lisinopril/hydrochlorothiazide fixed combinations should not be used for initial treatment of hypertension",hypertension,lisinopril
717919159,5/9/2015 19:00:43,1633312521,5/9/2015 18:59:10,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192-200,INSULIN therapy,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:02:02,1633312958,5/9/2015 19:00:37,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS preprandial insulin therapy concomitant metformin sulfonylurea adequate glycemic insulin therapy metformin sulfonylurea.,13-18-20-29-55-67-75-99-111-130-163-172-192-200-237-256,13-18-20-29-55-67-75-99-111-130-172-192-200-237-256-163,type 2 diabetes mellitus preprandial insulin therapy concomitant metformin sulfonylurea adequate glycemic INSULIN therapy metformin sulfonylurea.,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:16:29,1633323512,5/9/2015 19:16:15,false,clixsense,1,24763049,GBR,,,86.137.164.185,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192,INSULIN,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:20:23,1633328766,5/9/2015 19:19:20,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy,0-10-13-18-20-29-38-41-44-52-55-67-75,146-155-163-172-181-189-192-200-208-214-217-220-232-237,patients without adequate glycemic control on INSULIN therapy alone or in combination with metformin,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:30:15,1633338644,5/9/2015 19:29:58,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192-200,INSULIN therapy,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:41:03,1633343026,5/9/2015 19:40:39,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192,INSULIN,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:42:08,1633343336,5/9/2015 19:41:45,false,elite,1,30064988,GBR,,,89.241.94.221,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192-200,INSULIN therapy,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:43:24,1633343766,5/9/2015 19:42:59,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192,INSULIN,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:46:57,1633345054,5/9/2015 19:46:13,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,192,INSULIN,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919159,5/9/2015 19:47:10,1633345137,5/9/2015 19:46:33,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,13,192,,,37,199,TYPE 2 DIABETES MELLITUS,INSULIN,TYPE 2 DIABETES MELLITUS,13-18-20-29,189-192,on INSULIN,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea.,13 18 20 29,192,13,192,-1,37,199,TWrex-cause,800335,Treatment of type 2 diabetes mellitus as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on insulin therapy alone or in combination with metformin and/or a sulfonylurea,type 2 diabetes mellitus,insulin
717919160,5/9/2015 19:04:47,1633313875,5/9/2015 19:04:30,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 19:20:00,1633328273,5/9/2015 19:19:40,false,clixsense,1,24763049,GBR,,,86.137.164.185,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 19:33:49,1633340125,5/9/2015 19:33:36,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 19:47:56,1633345371,5/9/2015 19:47:40,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 19:48:00,1633345406,5/9/2015 19:47:42,false,elite,1,30064988,GBR,,,89.241.94.221,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,78-86-90-98,insulin and INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 19:53:01,1633346937,5/9/2015 19:52:38,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 20:00:10,1633349267,5/9/2015 19:57:12,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,69-78-86-90-98,buffered insulin and INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 20:45:07,1633364936,5/9/2015 20:44:41,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 20:49:51,1633366631,5/9/2015 20:49:22,false,pocketmoneygpt,1,27694731,CAN,BC,Coquitlam,172.218.124.118,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,90-98,INSULIN LISPRO,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919160,5/9/2015 21:13:52,1633375137,5/9/2015 21:13:06,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,172,90,,,187,104,TYPE 1 DIABETES,INSULIN LISPRO,TYPE 1 DIABETES.,172-177-179,69-78-86-90-98-105-108-119,buffered insulin and INSULIN LISPRO in continuous subcutaneous,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.",172 177 179,90 98,172,90,-1,187,104,TWrex-cause,800519,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes",type 1 diabetes,insulin lispro
717919161,5/9/2015 19:21:00,1633329679,5/9/2015 19:20:45,false,clixsense,1,24763049,GBR,,,86.137.164.185,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,83,"PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 19:34:40,1633340566,5/9/2015 19:34:27,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,83,"PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 19:49:20,1633345877,5/9/2015 19:49:00,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,72-83-95-99,"allethrin, PERMETHRIN, and ivermectin.","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 19:49:24,1633345883,5/9/2015 19:48:49,false,elite,1,30064988,GBR,,,89.241.94.221,59,83,,,66,93,SCABIES,PERMETHRIN,endemic outbreaks of SCABIES,38-46-56-59,59-83,"scabies PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 19:54:21,1633347403,5/9/2015 19:53:58,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,83,"PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 20:01:47,1633349694,5/9/2015 20:01:33,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,59,83,,,66,93,SCABIES,PERMETHRIN,"SCABIES with allethrin, permethrin, and ivermectin.",59-67-72-83-95-99,59-67-72-83-95-99,"scabies with allethrin, PERMETHRIN, and ivermectin.","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 20:46:46,1633365500,5/9/2015 20:46:30,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,83,"PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 21:14:58,1633375525,5/9/2015 21:14:36,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,83,"PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 21:21:42,1633378226,5/9/2015 21:21:31,false,elite,1,32601739,GBR,H4,Leicester,89.243.105.120,59,83,,,66,93,SCABIES,PERMETHRIN,SCABIES,59,83,"PERMETHRIN,","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919161,5/9/2015 21:22:19,1633378464,5/9/2015 21:21:31,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,59,83,,,66,93,SCABIES,PERMETHRIN,endemic outbreaks of SCABIES,38-46-56-59,72-83-95-99,"allethrin, PERMETHRIN, and ivermectin.","Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.",59,83,59,83,-1,66,93,TWrex-cause,804661,"Paasch U, Haustein U-F: Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin",scabies,permethrin
717919162,5/9/2015 19:02:12,1633313031,5/9/2015 19:01:55,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"MIDDLE EAR,",74-81,38-45,OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:08:37,1633315258,5/9/2015 19:07:48,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"Acute chronic otitis Otitis media infection MIDDLE EAR, facial nerve nerve canal.",6-16-24-38-45-57-74-81-110-117-166-179,6-16-24-38-45-54-57-74-81-110-117-166-179,"Acute chronic otitis OTITIS MEDIA an infection middle ear, facial nerve nerve canal.","edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:17:33,1633324960,5/9/2015 19:17:19,false,clixsense,1,24763049,GBR,,,86.137.164.185,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"MIDDLE EAR,",74-81,38-45,OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:22:56,1633332394,5/9/2015 19:22:07,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"Acute and chronic otitis is an infection in the MIDDLE EAR, which can spread to the facial nerve and inflame it,",6-12-16-24-51-54-57-67-70-74-81-86-92-96-103-106-110-117-123-127-135,16-24-31-38-45-51-54-57-67-74-81-70,"chronic otitis media OTITIS MEDIA is an infection in the middle ear,","edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:31:24,1633339131,5/9/2015 19:31:09,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"MIDDLE EAR,",74-81,38-45,OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:42:49,1633343576,5/9/2015 19:42:28,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"MIDDLE EAR,",74-81,38-45,OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:44:32,1633344149,5/9/2015 19:44:07,false,elite,1,30064988,GBR,,,89.241.94.221,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"infection in the MIDDLE EAR,",57-67-70-74-81,16-38-45,chronic OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:44:47,1633344235,5/9/2015 19:44:29,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"MIDDLE EAR,",74-81,16-24-31-38-45,chronic otitis media OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:48:55,1633345748,5/9/2015 19:48:19,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"MIDDLE EAR,",74-81,16-38-45,chronic OTITIS MEDIA,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919162,5/9/2015 19:49:40,1633345989,5/9/2015 19:49:24,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,74,38,,,84,50,MIDDLE EAR,OTITIS MEDIA,"infection in the MIDDLE EAR,",57-67-70-74-81,16-24-31-38-45-51-54-57,chronic otitis media OTITIS MEDIA is an infection,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal.",74 81,38 45,74,38,-1,84,50,TWrex-cause,802815,"edit] Acute and chronic otitis media  Otitis media is an infection in the middle ear, which can spread to the facial nerve and inflame it, causing compression of the nerve in its canal",middle ear,otitis media
717919163,5/9/2015 16:18:12,1633250482,5/9/2015 16:17:53,false,gifthunterclub,1,30901412,GBR,G5,Margate,85.210.119.8,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,"café au lait SPOTS greater than 5 puberty,",33-38-41-46-52-60-65-138,33-38-41-160-171-180-183-201-206-46,café au lait spots diagnostic features of NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:19:15,1633250816,5/9/2015 16:19:01,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS,33-38-41-46,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:24:25,1633252732,5/9/2015 16:24:05,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS,33-38-41-46,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:29:25,1633254769,5/9/2015 16:29:08,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,SPOTS,46,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:33:20,1633256184,5/9/2015 16:32:06,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS,33-38-46-41,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:49:03,1633261758,5/9/2015 16:48:23,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS,33-38-41-46,183,NEUROFIBROMATOSIS,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:51:16,1633262647,5/9/2015 16:51:01,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS,33-38-41-46,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:52:17,1633263213,5/9/2015 16:51:55,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS 5,33-38-41-46-65,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:54:06,1633264402,5/9/2015 16:53:07,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,"Specifically, having six or more café au lait SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",0-14-21-25-28-33-38-41-46-52-60-65-67-70-73-82-89-98-101-109-114-117-120-123-132-138-147-151-160-171-180-183-201-206,0-14-21-25-28-33-38-41-46-52-60-65-67-70-73-82-89-98-101-109-114-117-120-123-132-138-147-160-171-180-183-201-206-151,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS type I.","Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919163,5/9/2015 16:57:27,1633265950,5/9/2015 16:56:08,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,46,183,,,51,200,SPOT,NEUROFIBROMATOSIS,café au lait SPOTS,33-38-41-46,183-201-206,NEUROFIBROMATOSIS type I.,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I.",46,183,46,183,1,51,200,TWrex-cause,812642,"Specifically, having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of neurofibromatosis type I",spot,neurofibromatosis
717919164,5/9/2015 17:53:09,1633287674,5/9/2015 17:52:53,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,70,DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 17:58:32,1633289631,5/9/2015 17:57:30,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,70,DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:11:17,1633293919,5/9/2015 18:10:51,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,0,69,,,8,73,OVERDOSE,DRUG,"OVERDOSe inhalation, injection, absorption",0-26-38-52,0-26-38-52-63-66-70-75-80-84-101,"Overdose inhalation, injection, absorption of the DRUg from the gastrointestinal tract","Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:11:32,1633294026,5/9/2015 18:11:15,false,instagc,1,24252915,GBR,,,80.44.147.241,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,70,DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:13:35,1633294770,5/9/2015 18:13:25,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,70,DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:28:42,1633300460,5/9/2015 18:26:56,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,52-63-66-70,absorption of the DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:45:50,1633307268,5/9/2015 18:45:15,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,70,DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:48:49,1633308524,5/9/2015 18:48:19,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,0,69,,,8,73,OVERDOSE,DRUG,"OVERDOSe inhalation, injection, absorption gastrointestinal tract",0-26-38-52-84-101,0-26-38-52-84-101,"Overdose inhalation, injection, absorption gastrointestinal tract","Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:50:13,1633309092,5/9/2015 18:49:31,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,0,69,,,8,73,OVERDOSE,DRUG,"OVERDOSe can result from inhalation,",0-10-14-21-26,70-75-80-84-101,DRUg from the gastrointestinal tract,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919164,5/9/2015 18:50:30,1633309172,5/9/2015 18:49:57,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,0,69,,,8,73,OVERDOSE,DRUG,OVERDOSe,0,70,DRUg,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",0,,0,69,1,8,73,TWrex-cause,810495,"Overdose can result from inhalation, injection, or absorption of the drug from the gastrointestinal tract ('body packing')",overdose,drug
717919165,5/9/2015 17:54:09,1633288020,5/9/2015 17:53:51,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,124,168,,,132,179,MELANOMA,DACARBAZINE,MELANOMA,124,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:01:04,1633290412,5/9/2015 17:59:30,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA,113-124,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:12:31,1633294362,5/9/2015 18:12:11,false,instagc,1,24252915,GBR,,,80.44.147.241,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA,113-124,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:12:57,1633294511,5/9/2015 18:12:14,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,124,168,,,132,179,MELANOMA,DACARBAZINE,"MELANOMA chemotherapy cisplatin, dacarbazine, tamoxifen interleukin 2 interferon alfa 2b.",124-139-157-168-185-224-236-242-253-258,113-139-157-168-185-224-236-242-253-258-124,"metastatic melanoma chemotherapy cisplatin, DACARBAZINE, tamoxifen interleukin 2 interferon alfa 2b.","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:14:20,1633295083,5/9/2015 18:14:04,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA,113-124,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:31:38,1633301401,5/9/2015 18:30:07,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA,113-124,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:47:33,1633307948,5/9/2015 18:47:11,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA,124-113,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:50:38,1633309213,5/9/2015 18:49:52,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,124,168,,,132,179,MELANOMA,DACARBAZINE,"metastatic MELANOMA chemotherapy cisplatin, dacarbazine, tamoxifen interleukin - 2 interferon alfa - 2b.",113-124-139-157-168-185-224-235-236-242-253-257-258,113-124-139-157-168-185-224-235-236-242-253-257-258,"metastatic melanoma chemotherapy cisplatin, DACARBAZINE, tamoxifen interleukin - 2 interferon alfa - 2b.","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:51:53,1633309635,5/9/2015 18:51:17,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA with,113-124-152,157-168-181-185,"cisplatin, DACARBAZINE, and tamoxifen","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919165,5/9/2015 18:52:14,1633309762,5/9/2015 18:51:38,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,124,168,,,132,179,MELANOMA,DACARBAZINE,metastatic MELANOMA,113-124,168,"DACARBAZINE,","Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.",124,168,124,168,-1,132,179,TWrex-cause,803731,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b",melanoma,dacarbazine
717919166,5/9/2015 19:21:31,1633330356,5/9/2015 19:21:19,false,clixsense,1,24763049,GBR,,,86.137.164.185,70,265,,,82,267,SENSORY LOSS,MS,"SENSORY LOSS,",70-78,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 19:35:17,1633340819,5/9/2015 19:35:05,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,70,265,,,82,267,SENSORY LOSS,MS,"SENSORY LOSS,",70-78,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 19:50:29,1633346216,5/9/2015 19:50:08,false,elite,1,30064988,GBR,,,89.241.94.221,70,265,,,82,267,SENSORY LOSS,MS,"Babinski signs ◊ SENSORY LOSS,",53-62-68-70-78,240-252-265,Examination Elements MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 19:50:41,1633346273,5/9/2015 19:50:12,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,70,265,,,82,267,SENSORY LOSS,MS,"Babinski signs ◊ SENSORY LOSS, level",53-62-68-70-78-103,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 19:56:11,1633348010,5/9/2015 19:55:38,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,70,265,,,82,267,SENSORY LOSS,MS,"SENSORY LOSS,",70-78,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 20:02:38,1633349981,5/9/2015 20:02:18,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,70,265,,,82,267,SENSORY LOSS,MS,"◊ SENSORY LOSS, especially sensory level and impaired vibratory and proprioceptive sensation in limbs",68-70-78-84-95-103-109-113-122-132-136-151-161-164,240-252-261-265,Examination Elements for MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 20:47:58,1633365952,5/9/2015 20:47:38,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,70,265,,,82,267,SENSORY LOSS,MS,"Babinski signs ◊ SENSORY LOSS,",53-62-68-70-78,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 21:16:13,1633376084,5/9/2015 21:16:01,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,70,265,,,82,267,SENSORY LOSS,MS,"SENSORY LOSS,",70-78,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 21:22:17,1633378434,5/9/2015 21:22:08,false,elite,1,32601739,GBR,H4,Leicester,89.243.105.120,70,265,,,82,267,SENSORY LOSS,MS,"SENSORY LOSS,",70-78,265,MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919166,5/9/2015 21:23:03,1633378678,5/9/2015 21:22:49,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,70,265,,,82,267,SENSORY LOSS,MS,"SENSORY LOSS,",70-78,240-252-261-265,Examination Elements for MS.,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS.",70 78,265,70,265,1,82,267,TWrex-cause,813602,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ Sensory loss, especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",sensory loss,MS
717919167,5/9/2015 16:29:08,1633254651,5/9/2015 16:28:53,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION with ST segment elevation.,64-75-86-91-94-102,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 16:46:49,1633261008,5/9/2015 16:46:03,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION,64-75,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 16:57:25,1633265943,5/9/2015 16:56:54,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION with ST - segment elevation.,64-75-86-91-93-94-102,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 16:59:59,1633266941,5/9/2015 16:59:35,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION,64-75,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 17:07:10,1633269988,5/9/2015 17:06:48,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION,64-75,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 17:11:17,1633271286,5/9/2015 17:10:34,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION,64-75,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 17:12:47,1633271788,5/9/2015 17:12:23,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,75,27,,,85,34,INFARCTION,ASPIRIN,therapy for myocardial INFARCTION,52-60-64-75,27-35-39-52,ASPIRIN and fibrinolytic therapy,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 17:34:06,1633280341,5/9/2015 17:33:41,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,75,27,,,85,34,INFARCTION,ASPIRIN,INFARCTION,75,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 17:35:22,1633280897,5/9/2015 17:34:49,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION,64-75,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919167,5/9/2015 17:44:37,1633284256,5/9/2015 17:44:21,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,75,27,,,85,34,INFARCTION,ASPIRIN,myocardial INFARCTION with ST segment elevation.,64-75-86-91-94-102,27,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,75,27,75,27,-1,85,34,TWrex-cause,804206,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
717919168,5/9/2015 17:51:05,1633286686,5/9/2015 17:50:47,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,HEMORRHAGE,48,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 17:54:33,1633288149,5/9/2015 17:53:53,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE,28-40-48,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:07:51,1633292787,5/9/2015 18:07:25,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE neuroblastoma Wilms' tumor.,28-40-48-104-121-128,28-40-48-77-85-104-121-128,"spontaneous adrenal hemorrhage adrenal masses, NEUROBLASTOMA Wilms' tumor.","Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:08:43,1633293171,5/9/2015 18:08:08,false,instagc,1,24252915,GBR,,,80.44.147.241,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE,28-40-48,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:11:26,1633293967,5/9/2015 18:11:05,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,adrenal HEMORRHAGE,40-48,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:18:45,1633296825,5/9/2015 18:17:33,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE,28-40-48,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:39:58,1633304333,5/9/2015 18:39:22,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE,40-48-28,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:42:34,1633305575,5/9/2015 18:42:04,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,"HEMORRHAGE produce large adrenal masses,",48-63-71-77-85,63-71-77-104-85,"produce large adrenal masses, NEUROBLASTOMA","Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:43:22,1633305967,5/9/2015 18:43:10,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE,28-40-48,104,NEUROBLASTOMA,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919168,5/9/2015 18:45:51,1633307276,5/9/2015 18:44:37,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,48,104,,,58,117,HEMORRHAGE,NEUROBLASTOMA,spontaneous adrenal HEMORRHAGE,28-40-48,77-85-104-121-128,"adrenal masses, NEUROBLASTOMA Wilms' tumor.","Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor.",48,104,48,104,1,58,117,TWrex-cause,814144,"Less commonly, in newborns, spontaneous adrenal hemorrhage may produce large adrenal masses, simulating neuroblastoma or Wilms' tumor",hemorrhage,neuroblastoma
717919169,5/9/2015 19:03:19,1633313498,5/9/2015 19:02:52,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,58,ENDOMETRIOSIS,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:18:19,1633325942,5/9/2015 19:18:04,false,clixsense,1,24763049,GBR,,,86.137.164.185,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,58,ENDOMETRIOSIS,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:24:51,1633335250,5/9/2015 19:24:20,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,105,58,,,109,71,PAIN,ENDOMETRIOSIS,endometriosis was found to be the cause of the PAIN in 70 to 80% of cases.,58-72-76-82-85-88-92-98-101-105-110-113-116-119-123-126,37-45-52-58-72-76-82-85-88-92-98-101-105-110-113-116-119-126-123,"chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the pain in 70 to 80% of cases.","In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:32:18,1633339576,5/9/2015 19:31:58,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,58,ENDOMETRIOSIS,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:45:48,1633344579,5/9/2015 19:44:19,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,105,58,,,109,71,PAIN,ENDOMETRIOSIS,endometriosis PAIN,105-58,45-52-58,"pelvic pain, ENDOMETRIOSIS","In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:45:57,1633344633,5/9/2015 19:45:38,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,58,ENDOMETRIOSIS,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:46:03,1633344659,5/9/2015 19:45:41,false,elite,1,30064988,GBR,,,89.241.94.221,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,37-45-52-58,"chronic pelvic pain, ENDOMETRIOSIS","In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:50:31,1633346224,5/9/2015 19:50:05,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,58,ENDOMETRIOSIS,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 19:50:34,1633346242,5/9/2015 19:50:15,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,37-45-52-58,"chronic pelvic pain, ENDOMETRIOSIS","In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919169,5/9/2015 20:13:24,1633354034,5/9/2015 20:13:12,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,105,58,,,109,71,PAIN,ENDOMETRIOSIS,PAIN,105,58,ENDOMETRIOSIS,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases.",105,58,105,58,1,109,71,TWrex-cause,813492,"In three large studies of women with chronic pelvic pain, endometriosis was found to be the cause of the pain in 70 to 80% of cases",pain,endometriosis
717919170,5/9/2015 16:19:32,1633250918,5/9/2015 16:19:16,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,PULMONARY EMBOLISM,261-271,0-4-14-21,Low molecular weight HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:24:53,1633252949,5/9/2015 16:24:26,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,PULMONARY EMBOLISM,261-271,21,HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:29:39,1633254825,5/9/2015 16:29:27,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,"low molecular weight PULMONARY EMBOLISM Stockings,",240-244-254-261-271-280,0-4-14-21,Low molecular weight HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:34:41,1633256656,5/9/2015 16:33:21,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,PULMONARY EMBOLISM,261-271,0-4-14-21,Low molecular weight HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:49:47,1633262035,5/9/2015 16:49:03,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,PULMONARY EMBOLISM,261-271,21,HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:52:05,1633263104,5/9/2015 16:51:17,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,"low - molecular - weight PULMONARY EMBOLISM Stockings,",240-243-244-253-254-261-271-280,0-3-4-13-14-21,Low - molecular - weight HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:52:40,1633263429,5/9/2015 16:52:19,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,PULMONARY EMBOLISM,261-271,0-4-14-21-33,Low molecular weight HEPARIN 7,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:55:43,1633265217,5/9/2015 16:54:07,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,"Low molecular weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy Hematology low molecular weight PULMONARY EMBOLISM Stockings,",0-4-14-21-29-33-35-40-44-49-59-64-76-86-90-101-105-108-113-126-240-244-254-261-271-280,0-4-14-21-29-33-35-40-44-49-59-64-76-86-90-101-105-108-113-126-240-244-254-261-271-280,"Low molecular weight HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy Hematology low molecular weight Pulmonary embolism Stockings,","Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 16:58:30,1633266323,5/9/2015 16:57:30,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,low molecular weight PULMONARY EMBOLISM,240-244-254-261-271,0-4-14-21,Low molecular weight HEPARIN,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919170,5/9/2015 17:00:14,1633266988,5/9/2015 16:58:54,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,261,21,,,279,28,PULMONARY EMBOLISM,HEPARIN,PULMONARY EMBOLISM,261-271,0-4-14-21-29-33-35,Low molecular weight HEPARIN for 7 days,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",261 271,21,261,21,-1,279,28,TWrex-cause,804558,"Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, low-molecular-weight Pulmonary embolism Stockings, compression Venous thromboembolism Venous Thrombosis  ACP Journal Club",pulmonary embolism,heparin
717919171,5/9/2015 19:01:32,1633312773,5/9/2015 19:01:16,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,73,38,,,82,41,SCOLIOSIS,NP,"SCOLIOSIS,",73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:05:31,1633314080,5/9/2015 19:04:43,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,73,38,,,82,41,SCOLIOSIS,NP,"glaucoma SCOLIOSIS, poorly developed spines.",60-73-98-108-91,38-60-73-91-98-108,"NPS glaucoma scoliosis, poorly developed spines.","Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:17:01,1633324210,5/9/2015 19:16:48,false,clixsense,1,24763049,GBR,,,86.137.164.185,73,38,,,82,41,SCOLIOSIS,NP,"SCOLIOSIS,",73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:21:31,1633330345,5/9/2015 19:20:57,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,73,38,,,82,41,SCOLIOSIS,NP,"people with NPS are more prone to glaucoma and SCOLIOSIS, due to poorly developed spines.",26-33-38-42-46-51-57-60-69-73-84-88-91-98-108,26-33-38-42-46-51-57-60-69-73-84-88-91-98-108,"people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.","Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:30:46,1633338833,5/9/2015 19:30:32,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,73,38,,,82,41,SCOLIOSIS,NP,"SCOLIOSIS,",73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:42:07,1633343339,5/9/2015 19:41:31,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,73,38,,,82,41,SCOLIOSIS,NP,"glaucoma and SCOLIOSIS,",60-69-73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:43:23,1633343772,5/9/2015 19:42:59,false,elite,1,30064988,GBR,,,89.241.94.221,73,38,,,82,41,SCOLIOSIS,NP,"glaucoma and SCOLIOSIS,",60-69-73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:44:04,1633344004,5/9/2015 19:43:50,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,73,38,,,82,41,SCOLIOSIS,NP,"SCOLIOSIS,",73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:47:52,1633345341,5/9/2015 19:47:27,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,73,38,,,82,41,SCOLIOSIS,NP,"SCOLIOSIS,",73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919171,5/9/2015 19:48:44,1633345668,5/9/2015 19:47:50,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,73,38,,,82,41,SCOLIOSIS,NP,"SCOLIOSIS,",73,38,NPS,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines.",73,38,73,38,1,82,41,TWrex-cause,813516,"Also, some research shows people with NPS are more prone to glaucoma and scoliosis, due to poorly developed spines",scoliosis,np
717919172,5/9/2015 16:50:03,1633262140,5/9/2015 16:49:23,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:01:51,1633267828,5/9/2015 17:01:16,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:08:45,1633270515,5/9/2015 17:08:23,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:14:08,1633272410,5/9/2015 17:13:24,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:16:19,1633273353,5/9/2015 17:16:03,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,prophylaxis to prevent HEADACHES,85-97-100-108,0-12-22-25-33,COMMENTARY Treatment of CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:35:14,1633280861,5/9/2015 17:34:50,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,prophylaxis HEADACHES,85-108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:45:51,1633284632,5/9/2015 17:45:35,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 17:48:12,1633285514,5/9/2015 17:47:43,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 18:00:42,1633290352,5/9/2015 17:59:59,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,cluster headache headache prophylaxis HEADACHES,25-33-85-108-72,12-22-25-33-85-100-108,Treatment of CLUSTER HEADACHE prophylaxis prevent headaches,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919172,5/9/2015 18:03:49,1633291378,5/9/2015 18:03:28,false,instagc,1,24252915,GBR,,,80.44.147.241,108,25,,,117,41,HEADACHE,CLUSTER HEADACHE,HEADACHES,108,25-33,CLUSTER HEADACHE,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters.,108,25 33,108,25,1,117,41,TWrex-cause,814704,COMMENTARY  Treatment of cluster headache includes aborting any current headache and prophylaxis to prevent headaches both during the current cluster and in future clusters,headache,cluster headache
717919173,5/9/2015 18:15:24,1633295541,5/9/2015 18:15:04,false,instagc,1,24252915,GBR,,,80.44.147.241,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,91-98-108,56,"TERAZOSIN,","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:16:38,1633295988,5/9/2015 18:16:18,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,"terazosin, finasteride, benign prostatic HYPERPLASIA.",56-67-91-98-108,56-67-91-98-108,"TERAZOSIN, finasteride, benign prostatic hyperplasia.","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:40:18,1633304536,5/9/2015 18:39:50,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,91-98-108,56,"TERAZOSIN,","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:51:43,1633309551,5/9/2015 18:51:30,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,91-98-108,56,"TERAZOSIN,","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:56:29,1633311180,5/9/2015 18:56:01,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,"terazosin, finasteride, benign prostatic HYPERPLASIA.",56-67-91-98-108,56-67-91-98-108,"TERAZOSIN, finasteride, benign prostatic hyperplasia.","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:56:45,1633311299,5/9/2015 18:56:26,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,"The efficacy of terazosin, finasteride, or both in benign prostatic HYPERPLASIA.",40-44-53-56-67-80-88-91-98-108-83,40-44-53-56-67-80-83-88-91-98-108,"The efficacy of TERAZOSIN, finasteride, or both in benign prostatic hyperplasia.","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:57:23,1633311458,5/9/2015 18:57:06,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,98-108-91,56,"TERAZOSIN,","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 18:57:49,1633311675,5/9/2015 18:57:12,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,91-98-108,56,"TERAZOSIN,","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 19:14:52,1633321401,5/9/2015 19:14:40,false,clixsense,1,24763049,GBR,,,86.137.164.185,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,HYPERPLASIA.,108,56,"TERAZOSIN,","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919173,5/9/2015 19:16:05,1633322956,5/9/2015 19:15:47,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,108,56,,,119,65,HYPERPLASIA,TERAZOSIN,"The efficacy of terazosin, finasteride, or both in benign prostatic HYPERPLASIA.",40-44-53-56-67-80-88-91-98-108-83,40-44-53-56-67-80-83-88-91-98-108,"The efficacy of TERAZOSIN, finasteride, or both in benign prostatic hyperplasia.","Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia.",108,56,108,56,-1,119,65,TWrex-cause,804702,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia",hyperplasia,terazosin
717919174,5/9/2015 20:53:07,1633367771,5/9/2015 20:52:48,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,• HYPERSENSITIVITY,29-32,79-97,AMIKACIN aminoglycosides.,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/9/2015 21:28:09,1633380388,5/9/2015 21:27:54,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,• HYPERSENSITIVITY or serious toxic reactions to amikacin,29-32-49-52-60-66-76-79,60-66-76-79-88-91-97,toxic reactions to AMIKACIN or other aminoglycosides.,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/9/2015 22:13:27,1633396655,5/9/2015 22:13:13,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,• HYPERSENSITIVITY amikacin aminoglycosides.,29-32-79-97,32-79-97,Hypersensitivity AMIKACIN aminoglycosides.,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/9/2015 22:42:23,1633408166,5/9/2015 22:41:55,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,HYPERSENSITIVITY,32,79,AMIKACIN,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/9/2015 23:47:03,1633436321,5/9/2015 23:46:47,false,neodev,1,31139768,USA,DE,,108.59.10.153,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,Cautions Contraindications HYPERSENSITIVITY or serious toxic reactions to amikacin,0-10-32-49-52-60-66-79-76,60-66-76-79-88-91-97-52,serious toxic reactions to AMIKACIN or other aminoglycosides.,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/10/2015 00:17:23,1633450544,5/10/2015 00:16:57,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,HYPERSENSITIVITY,32,79,AMIKACIN,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/10/2015 00:35:18,1633457094,5/10/2015 00:35:01,false,neodev,1,20233773,USA,CA,San Jose,50.118.172.32,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,HYPERSENSITIVITY,32,79-32,Hypersensitivity AMIKACIN,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/10/2015 00:47:58,1633460914,5/10/2015 00:47:39,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,Cautions Contraindications • HYPERSENSITIVITY or serious toxic,0-10-29-32-49-52-60,79,AMIKACIN,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/10/2015 00:53:57,1633463032,5/10/2015 00:52:32,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,Cautions Contraindications • HYPERSENSITIVITY or serious toxic reactions to amikacin or other aminoglycosides.,0-10-29-32-49-52-60-66-76-79-88-91-97,0-10-32-49-60-66-76-79-88-91-97-52,Cautions Contraindications Hypersensitivity or serious toxic reactions to AMIKACIN or other aminoglycosides.,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919174,5/10/2015 00:54:58,1633463483,5/10/2015 00:53:11,false,quickrewards,1,8672587,USA,TX,El Paso,209.194.208.150,32,79,,,48,87,HYPERSENSITIVITY,AMIKACIN,HYPERSENSITIVITY toxic reactions,32-60-66,60-66-79,toxic reactions AMIKACIN,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides.,32,79,32,79,1,48,87,TWrex-cause,812473,Cautions  Contraindications  •  Hypersensitivity or serious toxic reactions to amikacin or other aminoglycosides,hypersensitivity,amikacin
717919175,5/9/2015 20:08:11,1633352114,5/9/2015 20:07:36,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,39,93,,,48,103,TULAREMIA,TULARENSIS,Deer Fly Fever) TULAREMIA is a febrile disease Francisella tularensis,22-27-31-39-49-52-54-62-81-93,70-77-81-93-105-110-120-128,caused by Francisella TULARENSIS that resembles typhoid fever.,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 20:11:58,1633353423,5/9/2015 20:11:29,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,39,93,,,48,103,TULAREMIA,TULARENSIS,TULAREMIA,39,81-93,Francisella TULARENSIS,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 20:52:12,1633367368,5/9/2015 20:51:49,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,39,93,,,48,103,TULAREMIA,TULARENSIS,TULAREMIA,39,81-93,Francisella TULARENSIS,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 21:19:04,1633377241,5/9/2015 21:18:51,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,39,93,,,48,103,TULAREMIA,TULARENSIS,TULAREMIA,39,81-93,Francisella TULARENSIS,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 21:27:17,1633380085,5/9/2015 21:26:43,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,39,93,,,48,103,TULAREMIA,TULARENSIS,TULAREMIA is a febrile disease caused by Francisella tularensis,39-49-52-54-62-70-77-81-93,39-49-62-70-77-81-93,Tularemia is disease caused by Francisella TULARENSIS,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 22:12:42,1633396319,5/9/2015 22:12:29,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,39,93,,,48,103,TULAREMIA,TULARENSIS,TULAREMIA Francisella tularensis,39-81-93,81-93-120,Francisella TULARENSIS typhoid,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 22:41:20,1633407678,5/9/2015 22:40:17,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,39,93,,,48,103,TULAREMIA,TULARENSIS,(Rabbit or Deer Fly Fever) TULAREMIA,11-22-27-31-39-19,81-93,Francisella TULARENSIS,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/9/2015 23:45:33,1633435706,5/9/2015 23:45:08,false,neodev,1,31139768,USA,DE,,108.59.10.153,39,93,,,48,103,TULAREMIA,TULARENSIS,(Rabbit Deer Fly Fever) TULAREMIA is a febrile,11-22-27-39-49-52-54-31,39-54-62-70-77-81-93-105-110-120-128,Tularemia febrile disease caused by Francisella TULARENSIS that resembles typhoid fever.,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/10/2015 00:14:38,1633449297,5/10/2015 00:14:19,false,prodege,1,27166596,USA,FL,Pompano Beach,68.177.119.2,39,93,,,48,103,TULAREMIA,TULARENSIS,Deer Fly Fever) TULAREMIA,22-27-31-39,93-120-128,TULARENSIS typhoid fever.,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919175,5/10/2015 00:16:30,1633450161,5/10/2015 00:15:20,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,39,93,,,48,103,TULAREMIA,TULARENSIS,(Rabbit or Deer Fly Fever) TULAREMIA,11-19-22-27-39-31,81-93,Francisella TULARENSIS,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever.,39,93,39,93,1,48,103,TWrex-cause,810800,TULAREMIA  (Rabbit or Deer Fly Fever)  Tularemia is a febrile disease caused by  Francisella tularensis  that resembles typhoid fever,tularemia,tularensis
717919176,5/9/2015 19:36:42,1633341419,5/9/2015 19:36:24,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychophysiologic PAIN,112-130,94-106,PSYCHOGENIC PAIN;,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 19:53:01,1633346939,5/9/2015 19:52:23,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychogenic pain; psychophysiologic PAIN,94-106-112-130,94-106-112-130,PSYCHOGENIC PAIN; psychophysiologic pain,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 19:53:20,1633347098,5/9/2015 19:52:56,false,elite,1,30064988,GBR,,,89.241.94.221,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychogenic pain; psychophysiologic PAIN,94-106-112-130,94-106,PSYCHOGENIC PAIN;,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 20:01:29,1633349618,5/9/2015 20:01:03,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychophysiologic PAIN,112-130,94-106,PSYCHOGENIC PAIN;,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 20:05:50,1633351231,5/9/2015 20:05:28,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychogenic pain; psychophysiologic PAIN,94-106-112-130,74-77-87-94-106-112-130,is sometimes called PSYCHOGENIC PAIN; psychophysiologic pain,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 20:50:04,1633366694,5/9/2015 20:49:44,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychogenic pain; psychophysiologic PAIN,94-106-112-130,94-106-112-130,PSYCHOGENIC PAIN; psychophysiologic pain,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 21:17:44,1633376637,5/9/2015 21:17:26,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychogenic pain; psychophysiologic PAIN,94-106-112-130,94-106-112-130,PSYCHOGENIC PAIN; psychophysiologic pain,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 21:25:30,1633379518,5/9/2015 21:25:06,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychophysiologic PAIN,112-130,94-106,PSYCHOGENIC PAIN;,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 22:11:32,1633395935,5/9/2015 22:11:18,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychogenic pain; psychophysiologic PAIN,94-106-112-130,94-106,PSYCHOGENIC PAIN;,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919176,5/9/2015 22:38:49,1633406631,5/9/2015 22:37:59,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,130,94,,,134,110,PAIN,PSYCHOGENIC PAIN,psychophysiologic PAIN,112-130,94-106,PSYCHOGENIC PAIN;,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena.,130,94 106,130,94,1,134,110,TWrex-cause,813297,Pain that is understood to be caused predominantly by psychologic factors is sometimes called psychogenic pain; psychophysiologic pain is a more accurate term because the pain results from interaction of physiologic and psychologic phenomena,pain,psychogenic pain
717919177,5/9/2015 19:03:37,1633313559,5/9/2015 19:03:20,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,"BACTEC 460 TB system,",176-183-187-190,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:18:35,1633326342,5/9/2015 19:18:20,false,clixsense,1,24763049,GBR,,,86.137.164.185,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,TB,187,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:32:54,1633339796,5/9/2015 19:32:28,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,"TB system,",187-190,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:46:24,1633344843,5/9/2015 19:45:58,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,"BACTEC 460 TB system,",176-183-187-190,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:46:26,1633344859,5/9/2015 19:45:49,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,BACTEC 460 TB,176-183-187,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:46:35,1633344928,5/9/2015 19:46:05,false,elite,1,30064988,GBR,,,89.241.94.221,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,"BACTEC 460 TB system,",176-183-187-190,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:51:24,1633346464,5/9/2015 19:50:39,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,"BACTEC 460 TB system,",176-183-187-190,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 19:53:03,1633346960,5/9/2015 19:50:35,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,the BACTEC 460 TB Lowenstein,172-176-183-187-202,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 20:13:38,1633354075,5/9/2015 20:13:25,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,TB,187,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919177,5/9/2015 20:17:09,1633355374,5/9/2015 20:15:57,false,instagc,1,21467491,USA,PA,Erie,107.9.206.78,187,101,,,189,127,TB,MYCOBACTERIUM TUBERCULOSIS,"mycobacterium tuberculosis BACTEC 460 TB system,",101-115-176-183-187-190,101-115,MYCOBACTERIUM TUBERCULOSIS,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium.",187,101 115,187,101,1,189,127,TWrex-cause,810857,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium",TB,mycobacterium tuberculosis
717919178,5/9/2015 16:50:46,1633262402,5/9/2015 16:50:04,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection,0-11,27-37,TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:02:16,1633268033,5/9/2015 17:01:52,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection,0-11,27-37,TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:09:09,1633270611,5/9/2015 17:08:47,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection,0-11,27-37,TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:14:51,1633272759,5/9/2015 17:14:09,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection with Trichuris,0-11-21-27,0-11-21-27-37,Whipworm Infection with TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:16:56,1633273656,5/9/2015 17:16:22,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection,0-11,0-11-21-27-37,Whipworm Infection with TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:35:25,1633280935,5/9/2015 17:35:15,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection Trichuris,0-11-27,0-11-27-37,Whipworm Infection TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:46:27,1633284839,5/9/2015 17:45:53,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM,0,27-37,TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 17:48:43,1633285775,5/9/2015 17:48:13,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Infection,0-11,27-37,TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 18:01:10,1633290436,5/9/2015 18:00:43,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM Trichuris trichiura,0-27-37,0-11-27-37,Whipworm Infection TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919178,5/9/2015 18:04:16,1633291560,5/9/2015 18:03:50,false,instagc,1,24252915,GBR,,,80.44.147.241,0,27,,,8,46,WHIPWORM,TRICHURIS TRICHIURA,WHIPWORM,0,27-37,TRICHURIS TRICHIURA,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States.,0,27 37,0,27,1,8,46,TWrex-cause,814974,Whipworm   Infection with  Trichuris trichiura  is widespread in tropical regions throughout the world and also occurs in rural areas of the southern United States,whipworm,Trichuris trichiura
717919179,5/9/2015 19:05:02,1633313922,5/9/2015 19:04:48,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 19:20:20,1633328745,5/9/2015 19:20:02,false,clixsense,1,24763049,GBR,,,86.137.164.185,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA,151,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 19:34:06,1633340342,5/9/2015 19:33:50,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA,151,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 19:48:17,1633345503,5/9/2015 19:47:57,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 19:48:23,1633345594,5/9/2015 19:48:02,false,elite,1,30064988,GBR,,,89.241.94.221,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 19:53:25,1633347123,5/9/2015 19:53:02,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 20:00:37,1633349361,5/9/2015 20:00:10,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41-53-56-60-70-73-82-90,THALIDOMIDE in the treatment of erythema nodosum leprosum,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 20:45:39,1633365126,5/9/2015 20:45:08,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 21:14:09,1633375253,5/9/2015 21:13:54,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919179,5/9/2015 21:21:15,1633378054,5/9/2015 21:20:03,false,elite,1,32601739,GBR,H4,Leicester,89.243.105.120,151,41,,,159,52,ERYTHEMA,THALIDOMIDE,ERYTHEMA nodosum leprosum.,151-160-168,41,THALIDOMIDE,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum.",151,41,151,41,-1,159,52,TWrex-cause,803403,"Hastings RC, Trautman JR, Enna CD et al. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum",erythema,thalidomide
717919180,5/9/2015 20:08:43,1633352264,5/9/2015 20:08:26,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,23,0,,,29,8,STROKE,WARFARIN,Warfarin reduced major STROKE more than aspirin,0-9-17-23-30-35-40,0-9-17-23-30-35-40,WARFARIN reduced major stroke more than aspirin,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 20:13:01,1633353883,5/9/2015 20:12:17,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,23,0,,,29,8,STROKE,WARFARIN,STROKE,23,0,WARFARIN,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 20:52:45,1633367665,5/9/2015 20:52:27,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,23,0,,,29,8,STROKE,WARFARIN,STROKE,23,0,WARFARIN,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 21:19:28,1633377355,5/9/2015 21:19:18,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,23,0,,,29,8,STROKE,WARFARIN,STROKE,23,0,WARFARIN,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 21:27:53,1633380275,5/9/2015 21:27:40,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,23,0,,,29,8,STROKE,WARFARIN,Warfarin reduced major STROKE more than aspirin,0-9-17-23-30-35-40,0-9-17-23,WARFARIN reduced major stroke,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 22:13:11,1633396562,5/9/2015 22:12:56,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,23,0,,,29,8,STROKE,WARFARIN,STROKE,23,0-23,WARFARIN stroke,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 22:41:54,1633407973,5/9/2015 22:41:39,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,23,0,,,29,8,STROKE,WARFARIN,major STROKE,17-23,0,WARFARIN,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/9/2015 23:46:44,1633436229,5/9/2015 23:45:54,false,neodev,1,31139768,USA,DE,,108.59.10.153,23,0,,,29,8,STROKE,WARFARIN,Warfarin reduced major STROKE more than aspirin in elderly patients,0-9-17-23-30-35-40-48-51-59,0-40-51-59,WARFARIN aspirin elderly patients,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/10/2015 00:16:56,1633450342,5/10/2015 00:16:43,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,23,0,,,29,8,STROKE,WARFARIN,major STROKE,17-23,0,WARFARIN,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919180,5/10/2015 00:34:59,1633457009,5/10/2015 00:34:28,false,neodev,1,20233773,USA,CA,San Jose,50.118.172.32,23,0,,,29,8,STROKE,WARFARIN,STROKE atrial fibrillation,23-73-80,0-73-80,WARFARIN atrial fibrillation,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin.,23,0,23,0,-1,29,8,TWrex-cause,803780,Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation Warfarin Anticoagulants Aspirin,stroke,warfarin
717919181,5/9/2015 16:12:08,1633248028,5/9/2015 16:11:56,false,clixsense,1,6352682,GBR,H9,London,2.125.111.168,49,66,,,54,74,FEVER,BORRELIA,Treatment of relapsing FEVER caused by Borrelia,26-36-39-49-55-62-66,49-55-62-66-75,fever caused by BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:17:15,1633250042,5/9/2015 16:16:56,false,gifthunterclub,1,30901412,GBR,G5,Margate,85.210.119.8,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER caused by Borrelia recurrentis.,39-49-55-62-66-75,49-55-62-66-75,fever caused by BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:18:26,1633250563,5/9/2015 16:18:12,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER,39-49,66,BORRELIA,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:23:32,1633252210,5/9/2015 16:23:19,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER,39-49,66-75,BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:28:39,1633254452,5/9/2015 16:28:29,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,49,66,,,54,74,FEVER,BORRELIA,FEVER,49,66-75,BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:29:56,1633254919,5/9/2015 16:28:48,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER,49-39,66-75,BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:33:17,1633256161,5/9/2015 16:32:58,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER,39-49,66-75,BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:40:02,1633258812,5/9/2015 16:39:54,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER,39-49,66-75,BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:46:11,1633260686,5/9/2015 16:45:26,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,49,66,,,54,74,FEVER,BORRELIA,FEVER,49,66,BORRELIA,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919181,5/9/2015 16:50:24,1633262237,5/9/2015 16:50:08,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,49,66,,,54,74,FEVER,BORRELIA,relapsing FEVER,39-49,66-75,BORRELIA recurrentis.,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis.",49,66,49,66,1,54,74,TWrex-cause,812351,"d ,   e  Relapsing Fever  Treatment of relapsing fever caused by  Borrelia recurrentis",fever,borrelia
717919182,5/9/2015 17:52:52,1633287508,5/9/2015 17:52:34,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 17:57:30,1633289340,5/9/2015 17:57:05,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:10:50,1633293775,5/9/2015 18:10:18,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS, gold salts, penicillamine, hydroxychloroquine, ankylosing spondylitis.",39-50-71-76-83-102-143-154,39-50-71-76-83-102,"rheumatoid arthritis, GOLD salts, penicillamine, hydroxychloroquine,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:11:14,1633293901,5/9/2015 18:10:58,false,instagc,1,24252915,GBR,,,80.44.147.241,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:13:24,1633294699,5/9/2015 18:12:55,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:26:50,1633299830,5/9/2015 18:25:37,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:45:14,1633306896,5/9/2015 18:44:58,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:48:18,1633308263,5/9/2015 18:47:43,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS, gold salts, penicillamine, hydroxychloroquine, ankylosing spondylitis.",39-50-71-83-102-143-154-76,39-50-71-83-102-143-154-76,"rheumatoid arthritis, GOLD salts, penicillamine, hydroxychloroquine, ankylosing spondylitis.","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:49:56,1633308927,5/9/2015 18:49:19,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,39-50-61-71-76-83-98-102,"rheumatoid arthritis, including GOLD salts, penicillamine, and hydroxychloroquine,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919182,5/9/2015 18:52:32,1633309873,5/9/2015 18:52:14,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,39,71,,,59,75,RHEUMATOID ARTHRITIS,GOLD,"RHEUMATOID ARTHRITIS,",39-50,71-76,"GOLD salts,","Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",39 50,71,39,71,-1,59,75,TWrex-cause,804532,"Other long-acting agents used to treat rheumatoid arthritis, including gold salts, penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis",rheumatoid arthritis,gold
717919183,5/9/2015 17:54:40,1633288181,5/9/2015 17:54:11,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,154,109,,,156,119,TB,TUBERCULIN,Quantiferon TB gold test (QFT G),139-154-157-162-167-172,109-125-130-120,TUBERCULIN skin test (TST),"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:01:50,1633290674,5/9/2015 18:01:05,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,154,109,,,156,119,TB,TUBERCULIN,Quantiferon ® TB gold test,139-151-154-157-162,109-120-125,TUBERCULIN skin test,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:12:54,1633294460,5/9/2015 18:12:32,false,instagc,1,24252915,GBR,,,80.44.147.241,154,109,,,156,119,TB,TUBERCULIN,Quantiferon ® TB gold test,139-151-154-157-162,109-120-125,TUBERCULIN skin test,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:13:34,1633294728,5/9/2015 18:12:58,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,154,109,,,156,119,TB,TUBERCULIN,M. tuberculosis Quantiferon ® TB,61-139-151-154-64,109-120-125-157-162-154,TUBERCULIN skin test TB gold test,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:14:37,1633295225,5/9/2015 18:14:21,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,154,109,,,156,119,TB,TUBERCULIN,Quantiferon ® TB gold test,139-151-154-157-162,109,TUBERCULIN,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:33:18,1633301881,5/9/2015 18:31:42,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,154,109,,,156,119,TB,TUBERCULIN,or Quantiferon ® TB gold test (QFT G),136-139-151-154-157-162-167-172,100-109-120-125-130,positive TUBERCULIN skin test (TST),"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:48:00,1633308131,5/9/2015 18:47:34,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,154,109,,,156,119,TB,TUBERCULIN,TB gold test,154-157-162,109-120-125,TUBERCULIN skin test,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:51:33,1633309535,5/9/2015 18:50:40,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,154,109,,,156,119,TB,TUBERCULIN,LTBI asymptomatic infection M. tuberculosis positive tuberculin skin test (TST) Quantiferon ® TB gold test (QFT G) TB.,24-32-45-61-64-100-109-120-125-130-139-151-154-157-162-167-172-213,24-32-45-61-64-100-109-120-125-130-139-151-154-157-162-167-172-213,LTBI asymptomatic infection M. tuberculosis positive TUBERCULIN skin test (TST) Quantiferon ® TB gold test (QFT G) TB.,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:52:09,1633309746,5/9/2015 18:51:54,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,154,109,,,156,119,TB,TUBERCULIN,Quantiferon ® TB gold test (QFT G),139-151-154-157-162-167-172,109-120-125-130,TUBERCULIN skin test (TST),"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919183,5/9/2015 18:52:19,1633309805,5/9/2015 18:51:44,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,154,109,,,156,119,TB,TUBERCULIN,Quantiferon ® TB gold test with no evidence of active TB.,139-151-154-157-162-175-180-183-192-195-213,79-87-95-98-100-109-120-125-136-139-154-157-162-175-180-183-192-195-213,usually defined as a positive TUBERCULIN skin test or Quantiferon TB gold test with no evidence of active TB.,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB.",154,109,154,109,-1,156,119,TWrex-cause,803021,"67 ,   72 ,   73 ,   o  LTBI is asymptomatic infection with  M. tuberculosis ; usually defined as a positive tuberculin skin test (TST) or Quantiferon ® -TB gold test (QFT-G) with no evidence of active (clinical) TB",TB,tuberculin
717919184,5/9/2015 17:53:50,1633287932,5/9/2015 17:53:37,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS,",0-17,140,HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 17:59:29,1633290006,5/9/2015 17:59:03,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS,",0-17,140,HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:12:10,1633294229,5/9/2015 18:11:56,false,instagc,1,24252915,GBR,,,80.44.147.241,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS,",0-17,97-140,antiglobulin HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:12:12,1633294250,5/9/2015 18:11:45,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS, neutrophilic leukocytosis, TTP HUS.",0-17-28-41-133-140,0-17-28-41-77-125-133-137-140-84,"Microangiopathic hemolysis, neutrophilic leukocytosis, Coombs test suggest TTP or HUS.","Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:14:02,1633294925,5/9/2015 18:13:50,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS,",0-17,140,HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:30:02,1633300886,5/9/2015 18:29:33,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS,",0-17,140,HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:47:10,1633307835,5/9/2015 18:46:07,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS,",0-17,140,HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:49:51,1633308897,5/9/2015 18:49:23,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS, neutrophilic leukocytosis, Coombs antiglobulin TTP HUS.",0-17-28-41-77-97-133-140,0-17-28-41-77-97-133-140,"Microangiopathic hemolysis, neutrophilic leukocytosis, Coombs antiglobulin TTP HUS.","Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:51:16,1633309460,5/9/2015 18:50:55,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS, neutrophilic leukocytosis,",0-17-28-41,133-137-140,TTP or HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919184,5/9/2015 18:51:43,1633309556,5/9/2015 18:50:38,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,17,140,,,26,143,HEMOLYSIS,HU,"Microangiopathic HEMOLYSIS, neutrophilic leukocytosis,",0-17-28-41,59-61-70-77-84-125-133-137-140-116,a negative direct Coombs test strongly suggest TTP or HUS.,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS.",17,140,17,140,1,26,143,TWrex-cause,813624,"Microangiopathic hemolysis, neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",hemolysis,Hu
717919185,5/9/2015 19:03:59,1633313659,5/9/2015 19:03:38,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,severe HYPERCHOLESTEROLEMIA.,74-81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:18:56,1633326778,5/9/2015 19:18:37,false,clixsense,1,24763049,GBR,,,86.137.164.185,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,HYPERCHOLESTEROLEMIA.,81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:33:08,1633339885,5/9/2015 19:32:54,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,HYPERCHOLESTEROLEMIA.,81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:46:41,1633344940,5/9/2015 19:46:25,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,severe HYPERCHOLESTEROLEMIA.,74-81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:46:46,1633344967,5/9/2015 19:46:28,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,HYPERCHOLESTEROLEMIA.,81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:46:56,1633345041,5/9/2015 19:46:37,false,elite,1,30064988,GBR,,,89.241.94.221,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,severe HYPERCHOLESTEROLEMIA.,74-81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:51:47,1633346592,5/9/2015 19:51:25,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,HYPERCHOLESTEROLEMIA.,81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 19:53:27,1633347125,5/9/2015 19:53:04,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,HYPERCHOLESTEROLEMIA.,81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 20:13:51,1633354151,5/9/2015 20:13:39,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,HYPERCHOLESTEROLEMIA.,81,41,ATORVASTATIN,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919185,5/9/2015 20:17:51,1633355558,5/9/2015 20:17:10,false,instagc,1,21467491,USA,PA,Erie,107.9.206.78,81,41,,,101,53,HYPERCHOLESTEROLEMIA,ATORVASTATIN,treatment of severe HYPERCHOLESTEROLEMIA.,61-71-74-81,31-34-37-41-54-57-61-71-74-81,"J, et al. ATORVASTATIN in the treatment of severe hypercholesterolemia.","Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia.",81,41,81,41,-1,101,53,TWrex-cause,803346,"Heinonen T, Stein E, Issacsohn J, et al. Atorvastatin in the treatment of severe hypercholesterolemia",hypercholesterolemia,atorvastatin
717919186,5/9/2015 19:54:22,1633347408,5/9/2015 19:53:50,false,elite,1,30064988,GBR,,,89.241.94.221,136,36,,,143,45,DISEASE,FOSCARNET,recurrent CMV DISEASE HIV infected adults or adolescents,122-132-136-154-158-167-174-177,18-30-36,ganciclovir or FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 20:06:47,1633351538,5/9/2015 20:06:27,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,136,36,,,143,45,DISEASE,FOSCARNET,CMV DISEASE in HIV infected,132-136-151-154-158,0-12-15-30-33-36-46-50-55-18,Alternative to IV ganciclovir or IV FOSCARNET for long term,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 20:10:23,1633352871,5/9/2015 20:10:01,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,136,36,,,143,45,DISEASE,FOSCARNET,CMV DISEASE,132-136,33-36,IV FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 20:50:44,1633366916,5/9/2015 20:50:29,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,136,36,,,143,45,DISEASE,FOSCARNET,CMV DISEASE in HIV infected,132-136-151-154-158,18-30-33-36,ganciclovir or IV FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 21:18:18,1633376863,5/9/2015 21:18:03,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,136,36,,,143,45,DISEASE,FOSCARNET,CMV DISEASE HIV,132-136-154,36-33,IV FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 21:26:00,1633379691,5/9/2015 21:25:43,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,136,36,,,143,45,DISEASE,FOSCARNET,recurrent CMV DISEASE,122-132-136,18-30-33-36-15,IV ganciclovir or IV FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 22:11:56,1633396046,5/9/2015 22:11:43,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,136,36,,,143,45,DISEASE,FOSCARNET,CMV DISEASE HIV infected,132-136-154-158,15-18-30-33-36,IV ganciclovir or IV FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 22:39:33,1633406890,5/9/2015 22:39:16,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,136,36,,,143,45,DISEASE,FOSCARNET,of recurrent CMV DISEASE in HIV infected,119-122-132-136-151-154-158,33-36,IV FOSCARNET,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 23:43:41,1633434888,5/9/2015 23:42:42,false,neodev,1,31139768,USA,DE,,108.59.10.153,136,36,,,143,45,DISEASE,FOSCARNET,CMV DISEASE HIV infected,132-136-154-158,15-18-33-36-46-50-55-60-72-87-75,IV ganciclovir IV FOSCARNET for long term suppressive or maintenance therapy,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919186,5/9/2015 23:56:26,1633440950,5/9/2015 23:56:10,false,neodev,1,12218487,CAN,ON,Oshawa,99.252.163.167,136,36,,,143,45,DISEASE,FOSCARNET,of recurrent CMV DISEASE in HIV infected,119-122-132-136-151-154-158,18-30-33-36-46-50-55,ganciclovir or IV FOSCARNET for long term,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +.,136,36,136,36,-1,143,45,TWrex-cause,800880,Alternative to IV ganciclovir or IV foscarnet for long-term suppressive or maintenance therapy (secondary prophylaxis) of recurrent CMV disease   +    in HIV-infected adults or adolescents   +,disease,foscarnet
717919187,5/9/2015 19:02:51,1633313333,5/9/2015 19:02:29,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,exaggerated postural sinus TACHYCARDIA,208-220-229-235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:18:02,1633325565,5/9/2015 19:17:49,false,clixsense,1,24763049,GBR,,,86.137.164.185,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,TACHYCARDIA,235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:24:20,1633334432,5/9/2015 19:23:26,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,exaggerated postural sinus TACHYCARDIA with or without orthostatic hypotension.,208-220-229-235-247-252-255-263-275,0-5-14-28-34-53-62-74-86-161-175-178-185-193-199-204-208-220-229-235,Main article: INAPPROPRIATE SINUS TACHYCARDIA Postural orthostatic tachycardia syndrome characterized by normal resting heart rate but exaggerated postural sinus tachycardia,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:31:57,1633339357,5/9/2015 19:31:42,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,TACHYCARDIA,235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:44:18,1633344067,5/9/2015 19:43:14,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,postural sinus TACHYCARDIA,220-235-229,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:45:37,1633344523,5/9/2015 19:45:23,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,postural sinus TACHYCARDIA,220-229-235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:45:39,1633344527,5/9/2015 19:45:11,false,elite,1,30064988,GBR,,,89.241.94.221,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,postural sinus TACHYCARDIA,220-229-235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:50:04,1633346058,5/9/2015 19:49:38,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,exaggerated postural sinus TACHYCARDIA,208-220-229-235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 19:50:14,1633346119,5/9/2015 19:49:57,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,TACHYCARDIA,235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919187,5/9/2015 20:13:11,1633354010,5/9/2015 20:13:00,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,235,14,,,246,45,TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA,TACHYCARDIA,235,14-28-34,INAPPROPRIATE SINUS TACHYCARDIA,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension.",235,14 28 34,235,14,1,246,45,TWrex-cause,813710,"Main article: Inappropriate sinus tachycardia [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated postural sinus tachycardia with or without orthostatic hypotension",tachycardia,inappropriate sinus tachycardia
717919188,5/9/2015 16:29:47,1633254865,5/9/2015 16:29:38,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,39,0,,,43,13,PAIN,ENDOMETRIOSIS,pelvic PAIN.,32-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 16:49:21,1633261903,5/9/2015 16:48:28,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,39,0,,,43,13,PAIN,ENDOMETRIOSIS,pelvic PAIN.,32-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 16:58:33,1633266348,5/9/2015 16:58:24,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,39,0,,,43,13,PAIN,ENDOMETRIOSIS,pelvic PAIN.,32-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:01:16,1633267475,5/9/2015 17:00:55,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,39,0,,,43,13,PAIN,ENDOMETRIOSIS,pelvic PAIN.,32-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:08:22,1633270430,5/9/2015 17:08:07,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,39,0,,,43,13,PAIN,ENDOMETRIOSIS,PAIN.,39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:13:20,1633272037,5/9/2015 17:12:43,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,39,0,,,43,13,PAIN,ENDOMETRIOSIS,pelvic PAIN.,32-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:16:00,1633273195,5/9/2015 17:15:26,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,39,0,,,43,13,PAIN,ENDOMETRIOSIS,mechanisms of pelvic PAIN.,18-29-32-39,0-14-18,ENDOMETRIOSIS and mechanisms,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:34:49,1633280679,5/9/2015 17:34:37,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,39,0,,,43,13,PAIN,ENDOMETRIOSIS,of PAIN.,29-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:45:33,1633284552,5/9/2015 17:45:16,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,39,0,,,43,13,PAIN,ENDOMETRIOSIS,pelvic PAIN.,32-39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919188,5/9/2015 17:47:42,1633285341,5/9/2015 17:46:32,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,39,0,,,43,13,PAIN,ENDOMETRIOSIS,PAIN.,39,0,ENDOMETRIOSIS,Endometriosis and mechanisms of pelvic pain.,39,0,39,0,1,43,13,TWrex-cause,814030,Endometriosis and mechanisms of pelvic pain,pain,endometriosis
717919189,5/9/2015 20:57:06,1633369054,5/9/2015 20:56:46,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,79,60,,,87,67,SEIZURE,SULFATE,SEIZURES,79,50-60-39,parenteral magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/9/2015 21:31:03,1633381415,5/9/2015 21:30:41,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,79,60,,,87,67,SEIZURE,SULFATE,parenteral magnesium to control SEIZURES,39-50-68-71-79,50-60-68-71-79,magnesium SULFATE to control seizures,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/9/2015 22:16:02,1633397606,5/9/2015 22:15:47,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,79,60,,,87,67,SEIZURE,SULFATE,SEIZURES hypomagnesemia,79-95,50-60,magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/9/2015 22:45:47,1633409670,5/9/2015 22:45:28,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,79,60,,,87,67,SEIZURE,SULFATE,SEIZURES unless,79-88,39-50-60,parenteral magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/9/2015 23:51:23,1633438327,5/9/2015 23:50:54,false,neodev,1,31139768,USA,DE,,108.59.10.153,79,60,,,87,67,SEIZURE,SULFATE,"sulfate to control SEIZURES unless hypomagnesemia confirmed,",60-68-71-79-88-95-119,28-32-35-39-50-60-68-71-79-88-95-110-114-119-20,"caution not to use parenteral magnesium SULFATE to control seizures unless hypomagnesemia has been confirmed,","67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/10/2015 00:20:39,1633451983,5/10/2015 00:20:16,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,79,60,,,87,67,SEIZURE,SULFATE,control SEIZURES,71-79,39-50-60,parenteral magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/10/2015 00:51:44,1633462290,5/10/2015 00:51:19,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,79,60,,,87,67,SEIZURE,SULFATE,SEIZURES,79,39-50-60,parenteral magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/10/2015 01:03:13,1633465989,5/10/2015 01:02:27,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,79,60,,,87,67,SEIZURE,SULFATE,SEIZURES,79,50-60,magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/10/2015 01:55:42,1633483816,5/10/2015 01:55:22,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,79,60,,,87,67,SEIZURE,SULFATE,SEIZURES,79,50-60-39,parenteral magnesium SULFATE,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919189,5/10/2015 02:02:14,1633486067,5/10/2015 02:01:41,false,clixsense,1,22947672,GBR,,,88.144.86.217,79,60,,,87,67,SEIZURE,SULFATE,parenteral ma<span id=transmark></span>gnesium sulfate control SEIZURES,39-60-71-79-50,39-50-60-68-71-79,parenteral magnesium SULFATE to control seizures,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered.",79,60,79,60,-1,87,67,TWrex-cause,804525,"67  Some clinicians caution not to use parenteral magnesium sulfate to control seizures unless hypomagnesemia has been confirmed, and to monitor serum magnesium concentration when administered",seizure,sulfate
717919190,5/9/2015 19:02:27,1633313169,5/9/2015 19:02:13,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:09:32,1633315755,5/9/2015 19:08:38,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,Single - dose intravenous therapy pamidronate HYPERCALCEMIA malignancy: 30 - 60 - 90 - mg dosages.,43-49-50-55-67-80-113-130-156-158-161-163-170-172-173-176,43-49-50-55-67-80-113-130-156-158-161-163-170-172-173-176,Single - dose intravenous therapy PAMIDRONATE hypercalcemia malignancy: 30 - 60 - 90 - mg dosages.,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:17:47,1633325276,5/9/2015 19:17:35,false,clixsense,1,24763049,GBR,,,86.137.164.185,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:23:25,1633333124,5/9/2015 19:22:58,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,pamidronate for the treatment of HYPERCALCEMIA of malignancy:,80-92-96-100-110-113-127-130,55-67-75-80-92-96-100-110-113-127-130,intravenous therapy with PAMIDRONATE for the treatment of hypercalcemia of malignancy:,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:31:41,1633339282,5/9/2015 19:31:25,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:43:14,1633343692,5/9/2015 19:42:51,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:45:09,1633344339,5/9/2015 19:44:34,false,elite,1,30064988,GBR,,,89.241.94.221,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:45:22,1633344394,5/9/2015 19:44:48,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:49:37,1633345957,5/9/2015 19:48:56,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,HYPERCALCEMIA,113,80,PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919190,5/9/2015 19:49:56,1633346032,5/9/2015 19:49:41,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,113,80,,,126,91,HYPERCALCEMIA,PAMIDRONATE,the treatment of HYPERCALCEMIA,96-100-110-113,55-67-75-80,intravenous therapy with PAMIDRONATE,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.",113,80,113,80,-1,126,91,TWrex-cause,800953,"Nussbaum SR, Younger J, VandePol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages",hypercalcemia,pamidronate
717919191,5/9/2015 19:04:29,1633313791,5/9/2015 19:04:13,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,5-12,Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:19:39,1633327706,5/9/2015 19:19:26,false,clixsense,1,24763049,GBR,,,86.137.164.185,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,12,SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:33:35,1633340044,5/9/2015 19:33:21,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,5-12,Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:47:19,1633345155,5/9/2015 19:47:00,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,0-5-12,173 Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:47:40,1633345266,5/9/2015 19:47:21,false,elite,1,30064988,GBR,,,89.241.94.221,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,"erythroderma, and LYMPHADENOPATHY.",65-79-83,5-12,Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:47:39,1633345270,5/9/2015 19:47:03,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,"erythroderma, and LYMPHADENOPATHY.",65-79-83,0-5-12,173 Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:52:37,1633346830,5/9/2015 19:52:10,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,0-5-12,173 Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 19:57:11,1633348359,5/9/2015 19:54:14,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,0-5-12-21-30-33-45-56-58-65-79-83,"173 Sezary SYNDROME consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.","173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 20:14:13,1633354257,5/9/2015 20:14:03,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,LYMPHADENOPATHY.,83,12,SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919191,5/9/2015 20:44:38,1633364743,5/9/2015 20:43:30,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,83,12,,,98,20,LYMPHADENOPATHY,SYNDROME,"erythroderma, LYMPHADENOPATHY.",65-83,5-12,Sezary SYNDROME,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy.",83,12,83,12,1,98,20,TWrex-cause,812876,"173  Sezary syndrome consists of circulating neoplastic T cells, erythroderma, and lymphadenopathy",lymphadenopathy,syndrome
717919192,5/9/2015 19:36:09,1633341173,5/9/2015 19:35:54,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,105,22,,,112,31,VERTIGO,MECLIZINE,VERTIGO,105,22,MECLIZINE),"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 19:52:00,1633346654,5/9/2015 19:51:35,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,105,22,,,112,31,VERTIGO,MECLIZINE,vestibular origin VERTIGO may mask symptoms,83-94-105-113-117-122,6-22,"dimenhydrinate, MECLIZINE)","e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 19:52:26,1633346798,5/9/2015 19:51:58,false,elite,1,30064988,GBR,,,89.241.94.221,105,22,,,112,31,VERTIGO,MECLIZINE,vomiting of vestibular origin and VERTIGO,71-83-94-101-105-80,6-22-33-38,"dimenhydrinate, MECLIZINE) Anti emetics","e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 20:00:43,1633349400,5/9/2015 20:00:15,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,105,22,,,112,31,VERTIGO,MECLIZINE,VERTIGO,105,22,MECLIZINE),"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 20:04:29,1633350741,5/9/2015 20:04:06,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,105,22,,,112,31,VERTIGO,MECLIZINE,vestibular origin and VERTIGO may mask symptoms of vestibular ototoxicity,83-94-101-105-113-117-122-131-134-145,22-37,MECLIZINE) -,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 20:49:18,1633366414,5/9/2015 20:48:54,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,105,22,,,112,31,VERTIGO,MECLIZINE,vestibular origin VERTIGO,83-94-105,6-22-33-38,"dimenhydrinate, MECLIZINE) Anti emetics","e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 21:17:07,1633376380,5/9/2015 21:16:51,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,105,22,,,112,31,VERTIGO,MECLIZINE,VERTIGO,105,0-6-22,"e.g., dimenhydrinate, MECLIZINE)","e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 21:24:46,1633379247,5/9/2015 21:23:45,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,105,22,,,112,31,VERTIGO,MECLIZINE,vestibular origin and VERTIGO symptoms,83-94-101-105-122,22-33-38,MECLIZINE) Anti emetics,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 21:33:46,1633382544,5/9/2015 21:33:38,false,instagc,1,31861996,USA,FL,Homestead,73.46.199.178,105,22,,,112,31,VERTIGO,MECLIZINE,vestibular origin and VERTIGO may mask symptoms,83-94-101-105-113-117-122,0-6-22-33-38-46,"e.g., dimenhydrinate, MECLIZINE) Anti emetics that","e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919192,5/9/2015 22:11:04,1633395809,5/9/2015 22:10:37,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,105,22,,,112,31,VERTIGO,MECLIZINE,nausea VERTIGO,105-60,0-22-60-71,"e.g., MECLIZINE) nausea vomiting","e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins.",105,22,105,22,-1,112,31,TWrex-cause,804937,"e.g., dimenhydrinate, meclizine) Anti-emetics that suppress nausea and vomiting of vestibular origin and vertigo may mask symptoms of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β-Lactam antibiotics (cephalosporins, penicillins",vertigo,meclizine
717919193,5/9/2015 19:01:54,1633312921,5/9/2015 19:01:34,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,89,25,,,93,34,PAIN,CAPSAICIN,intercourse related PAIN;,69-81-89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:07:48,1633314978,5/9/2015 19:05:33,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,89,25,,,93,34,PAIN,CAPSAICIN,intercourse - related PAIN; adjunctive treatment topical lidocaine,69-80-81-89-95-106-129-121,25-69-80-81-89-95-106-121-129,CAPSAICIN intercourse - related pain; adjunctive treatment topical lidocaine,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:17:18,1633324657,5/9/2015 19:17:03,false,clixsense,1,24763049,GBR,,,86.137.164.185,89,25,,,93,34,PAIN,CAPSAICIN,PAIN;,89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:22:05,1633331066,5/9/2015 19:21:32,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,89,25,,,93,34,PAIN,CAPSAICIN,capsaicin intercourse related PAIN; adjunctive treatment with,69-81-89-95-106-116-25,2-10-22-25-35-39-42-48-52-59-65-69-81-89,Topical application of CAPSAICIN for 12 weeks may reduce daily and intercourse related pain;,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:31:08,1633339003,5/9/2015 19:30:47,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,89,25,,,93,34,PAIN,CAPSAICIN,intercourse related PAIN;,69-81-89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:42:27,1633343424,5/9/2015 19:42:08,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,89,25,,,93,34,PAIN,CAPSAICIN,intercourse related PAIN;,69-81-89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:44:05,1633344008,5/9/2015 19:43:25,false,elite,1,30064988,GBR,,,89.241.94.221,89,25,,,93,34,PAIN,CAPSAICIN,intercourse related PAIN;,69-81-89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:44:27,1633344115,5/9/2015 19:44:05,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,89,25,,,93,34,PAIN,CAPSAICIN,PAIN;,89,2-10-22-25,Topical application of CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:48:18,1633345522,5/9/2015 19:47:52,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,89,25,,,93,34,PAIN,CAPSAICIN,intercourse related PAIN;,69-81-89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919193,5/9/2015 19:49:23,1633345884,5/9/2015 19:48:44,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,89,25,,,93,34,PAIN,CAPSAICIN,PAIN;,89,25,CAPSAICIN,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary.,89,25,89,25,-1,93,34,TWrex-cause,803950,• Topical application of capsaicin for 12 weeks may reduce daily and intercourse-related pain; adjunctive treatment with topical lidocaine is often necessary,pain,capsaicin
717919194,5/9/2015 19:05:32,1633314071,5/9/2015 19:05:03,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,", Meningococcal INFECTION",16-25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 19:20:43,1633329245,5/9/2015 19:20:22,false,clixsense,1,24763049,GBR,,,86.137.164.185,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,INFECTION,39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 19:34:26,1633340437,5/9/2015 19:34:07,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,Meningococcal INFECTION,25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 19:48:48,1633345687,5/9/2015 19:48:25,false,elite,1,30064988,GBR,,,89.241.94.221,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,Meningococcal INFECTION,25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 19:48:59,1633345763,5/9/2015 19:48:19,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,", 108 Meningococcal INFECTION",16-20-25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 19:53:57,1633347242,5/9/2015 19:53:26,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,108 Meningococcal INFECTION,20-25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 20:01:33,1633349628,5/9/2015 20:00:39,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,", INFECTION is acute, life threatening illness caused by Neisseria",16-39-49-62-67-79-87-94-98-55,79-87-94-98-108,illness caused by NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 20:46:28,1633365385,5/9/2015 20:45:42,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,", Meningococcal INFECTION",16-25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 21:14:35,1633375382,5/9/2015 21:14:11,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,"1 4 106 , 108 Meningococcal INFECTION",0-6-16-20-25-39-12,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919194,5/9/2015 21:21:29,1633378145,5/9/2015 21:21:17,false,elite,1,32601739,GBR,H4,Leicester,89.243.105.120,39,98,,,48,120,INFECTION,NEISSERIA MENINGITIDIS,Meningococcal INFECTION,25-39,98-108,NEISSERIA MENINGITIDIS,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route.",39,98 108,39,98,1,48,120,TWrex-cause,811176,"1 ,   4 ,   106 ,   108  Meningococcal infection is an acute, life-threatening illness caused by  Neisseria meningitidis  and is transmitted person-to-person by the respiratory route",infection,neisseria meningitidis
717919195,5/9/2015 20:08:26,1633352191,5/9/2015 20:08:12,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA is another common feature of ethylmalonic encephalopathy.,0-8-17-20-28-35-43-46-59,0-8-17-28-35-43-46-59-20,Chronic diarrhea is another common feature of ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 20:12:16,1633353539,5/9/2015 20:11:59,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA,0-8,46-59,ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 20:52:23,1633367464,5/9/2015 20:52:12,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA,0-8,46-59,ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 21:19:17,1633377302,5/9/2015 21:19:06,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA,0-8,46-59,ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 21:27:39,1633380224,5/9/2015 21:27:18,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA is feature of ethylmalonic encephalopathy.,0-8-17-35-46-59-43,46-59,ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 22:12:56,1633396424,5/9/2015 22:12:43,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA ethylmalonic encephalopathy.,0-8-46-59,0-8-46-59,Chronic diarrhea ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 22:41:39,1633407819,5/9/2015 22:41:21,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA,0-8,46-59,ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/9/2015 23:45:50,1633435874,5/9/2015 23:45:36,false,neodev,1,31139768,USA,DE,,108.59.10.153,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA,0-8,28-35-43-46-59,common feature of ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/10/2015 00:15:09,1633449483,5/10/2015 00:14:39,false,prodege,1,27166596,USA,FL,Pompano Beach,68.177.119.2,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,DIARRHEA ethylmalonic encephalopathy.,8-46-59,0-8-46-59,Chronic diarrhea ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919195,5/10/2015 00:16:41,1633450207,5/10/2015 00:16:31,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,8,46,,,16,73,DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,Chronic DIARRHEA,0-8,46-59,ETHYLMALONIC ENCEPHALOPATHY.,Chronic diarrhea is another common feature of ethylmalonic encephalopathy.,8,46 59,8,46,1,16,73,TWrex-cause,812888,Chronic diarrhea is another common feature of ethylmalonic encephalopathy,diarrhea,ethylmalonic encephalopathy
717919196,5/9/2015 18:14:21,1633295121,5/9/2015 18:14:06,false,instagc,1,24252915,GBR,,,80.44.147.241,64,88,,,71,96,OBESITY,SYNDROME,OBESITY hypoventilation syndrome.,64-72-88,64-72-88,obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:15:21,1633295522,5/9/2015 18:15:02,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,64,88,,,71,96,OBESITY,SYNDROME,hypoxemia OBESITY hypoventilation syndrome.,13-64-72-88,59-64-72-88-13,hypoxemia with obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:15:45,1633295676,5/9/2015 18:15:36,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,64,88,,,71,96,OBESITY,SYNDROME,OBESITY hypoventilation syndrome.,64-72-88,64-72-88,obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:38:05,1633303659,5/9/2015 18:37:28,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,64,88,,,71,96,OBESITY,SYNDROME,OBESITY hypoventilation syndrome.,64-72-88,64-72-88,obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:50:00,1633308969,5/9/2015 18:49:31,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,64,88,,,71,96,OBESITY,SYNDROME,OBESITY hypoventilation syndrome.,64-72-88,64-72-88,obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:53:58,1633310273,5/9/2015 18:53:21,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,64,88,,,71,96,OBESITY,SYNDROME,OBESITY hypoventilation syndrome.,64-72-88,64-72-88,obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:54:27,1633310463,5/9/2015 18:54:13,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,64,88,,,71,96,OBESITY,SYNDROME,hypoxemia OBESITY hypoventilation syndrome.,13-64-72-88,64-72-88-13,hypoxemia obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:54:30,1633310505,5/9/2015 18:53:02,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,64,88,,,71,96,OBESITY,SYNDROME,OBESITY hypoventilation syndrome.,64-72-88,64-72-88,obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 18:55:30,1633310869,5/9/2015 18:54:51,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,64,88,,,71,96,OBESITY,SYNDROME,hypoxemia present in individuals with OBESITY hypoventilation syndrome.,13-44-47-59-64-72-88-36,13-23-36-44-59-64-72-88-47,hypoxemia is present in individuals with obesity hypoventilation SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919196,5/9/2015 19:14:11,1633320459,5/9/2015 19:13:52,false,clixsense,1,24763049,GBR,,,86.137.164.185,64,88,,,71,96,OBESITY,SYNDROME,OBESITY,64,88,SYNDROME.,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome.",64,88,64,88,1,71,96,TWrex-cause,814376,"By contrast, hypoxemia is generally present in individuals with obesity hypoventilation syndrome",obesity,syndrome
717919197,5/9/2015 16:52:25,1633263255,5/9/2015 16:51:30,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 17:03:37,1633268567,5/9/2015 17:03:03,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 17:09:59,1633270956,5/9/2015 17:09:34,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 17:17:02,1633273703,5/9/2015 17:15:29,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,162-154,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 17:18:39,1633274362,5/9/2015 17:17:49,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,37,162,,,44,170,ANXIETY,DISORDER,"ANXIETY is very distressing,",37-45-48-53,154-162-171-174,anxiety DISORDER is present,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 17:47:22,1633285204,5/9/2015 17:46:56,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 17:49:42,1633286174,5/9/2015 17:49:11,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 18:02:21,1633290840,5/9/2015 18:01:42,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY anxiety disorder,37-162-154,37-154-162-53,"anxiety distressing, anxiety DISORDER","If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 18:05:02,1633291852,5/9/2015 18:04:43,false,instagc,1,24252915,GBR,,,80.44.147.241,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919197,5/9/2015 18:09:01,1633293239,5/9/2015 18:08:11,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,37,162,,,44,170,ANXIETY,DISORDER,ANXIETY,37,154-162,anxiety DISORDER,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment.",37,162,37,162,1,44,170,TWrex-cause,813712,"If other causes are not found and if anxiety is very distressing, interferes with functioning, and does not stop spontaneously within a few days, then an anxiety disorder is present and merits treatment",anxiety,disorder
717919198,5/9/2015 17:11:47,1633271401,5/9/2015 17:11:21,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,PULMONARY TB,158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 17:21:53,1633275544,5/9/2015 17:20:12,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,noncavity PULMONARY TB,148-158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 17:23:28,1633276189,5/9/2015 17:22:21,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,patients with noncavity PULMONARY TB,134-143-148-158-168,194-208-221-223,Mycobacterium tuberculosis ; RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 17:50:14,1633286388,5/9/2015 17:49:52,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,PULMONARY TB,158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 17:52:31,1633287409,5/9/2015 17:51:52,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,PULMONARY TB,158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 18:06:14,1633292266,5/9/2015 18:05:12,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,rifapentine isoniazid HIV seronegative noncavity PULMONARY TB Mycobacterium tuberculosis rifapentine rifampin isoniazid,34-78-117-148-158-168-194-208-223-256-293-121,34-78-117-120-121-158-168-194-208-221-223-256-293-148,rifapentine isoniazid HIV - seronegative noncavity pulmonary TB Mycobacterium tuberculosis ; RIFAPENTINE rifampin isoniazid,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 18:07:12,1633292592,5/9/2015 18:06:43,false,instagc,1,24252915,GBR,,,80.44.147.241,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,noncavity PULMONARY TB,148-158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 18:10:13,1633293625,5/9/2015 18:09:56,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,PULMONARY TB,158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 18:13:49,1633294858,5/9/2015 18:12:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,noncavity PULMONARY TB,148-158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919198,5/9/2015 18:41:11,1633304965,5/9/2015 18:40:54,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,158,223,,,170,234,PULMONARY TB,RIFAPENTINE,PULMONARY TB,158-168,223,RIFAPENTINE,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",158 168,223,158,223,-1,170,234,TWrex-cause,800768,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV-seronegative patients with noncavity pulmonary TB caused by susceptible  Mycobacterium tuberculosis ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase",pulmonary tb,rifapentine
717919199,5/9/2015 19:54:47,1633347545,5/9/2015 19:54:24,false,elite,1,30064988,GBR,,,89.241.94.221,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,ETIOLOGY DIPHTHERIA,3-13,38-41-55-57-62-71,C. DIPHTHERIAE a gram positive rod,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 20:07:02,1633351637,5/9/2015 20:06:48,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA is caused by C. diphtheriae,0-3-13-24-27-34-41-38,24-27-34-38-41,is caused by C. DIPHTHERIAE,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 20:10:54,1633353035,5/9/2015 20:10:25,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA,0-3-13,38-41,C. DIPHTHERIAE,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 20:51:19,1633367087,5/9/2015 20:50:48,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,ETIOLOGY DIPHTHERIA,3-13,24-27-34-38-41-55-57-62,is caused by C. DIPHTHERIAE a gram positive,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 21:18:31,1633376997,5/9/2015 21:18:20,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA,0-3-13,38-41,C. DIPHTHERIAE,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 21:26:27,1633379842,5/9/2015 21:26:02,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA,0-3-13,38-41,C. DIPHTHERIAE,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 22:12:10,1633396103,5/9/2015 22:11:57,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,ETIOLOGY DIPHTHERIA by,3-13-34,3-13-38-41,ETIOLOGY Diphtheria C. DIPHTHERIAE,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 22:39:54,1633407006,5/9/2015 22:39:34,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA,0-3-13,38-41,C. DIPHTHERIAE,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 23:44:21,1633435188,5/9/2015 23:43:46,false,neodev,1,31139768,USA,DE,,108.59.10.153,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA is caused by C. diphtheriae,0-3-13-24-27-34-41-38,24-27-34-38-41-55-57-62-13,Diphtheria is caused by C. DIPHTHERIAE a gram positive,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919199,5/9/2015 23:56:29,1633440963,5/9/2015 23:56:26,false,neodev,1,12218487,CAN,ON,Oshawa,99.252.163.167,13,38,,,23,52,DIPHTHERIA,C. DIPHTHERIAE,4 ETIOLOGY DIPHTHERIA is caused by,0-3-13-24-27-34,24-27-34-38-41-55-57-62,is caused by C. DIPHTHERIAE a gram positive,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end.",13,38 41,13,38,1,23,52,TWrex-cause,811838,"4  ETIOLOGY  Diphtheria is caused by  C. diphtheriae , a gram-positive rod with club-shaped swellings at each end",diphtheria,C. diphtheriae
717919200,5/9/2015 16:17:52,1633250297,5/9/2015 16:17:38,false,gifthunterclub,1,30901412,GBR,G5,Margate,85.210.119.8,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION in patients with chronic angina pectoris.,131-142-153-156-165-177-185-192,83-89-95-98-106-109-117,blind trial of ASPIRIN in primary prevention,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:19:01,1633250720,5/9/2015 16:18:48,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:24:03,1633252509,5/9/2015 16:23:48,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:29:07,1633254650,5/9/2015 16:28:53,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:32:05,1633255761,5/9/2015 16:31:13,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:33:58,1633256403,5/9/2015 16:33:49,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:48:22,1633261521,5/9/2015 16:47:51,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:51:00,1633262497,5/9/2015 16:50:42,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,98,ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:51:54,1633262961,5/9/2015 16:51:14,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,142,98,,,152,105,INFARCTION,ASPIRIN,myocardial INFARCTION,131-142,76-83-89-95-98,Double blind trial of ASPIRIN,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919200,5/9/2015 16:53:06,1633263696,5/9/2015 16:52:35,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,142,98,,,152,105,INFARCTION,ASPIRIN,Double blind trial of aspirin in primary prevention of myocardial INFARCTION in patients with stable chronic angina pectoris.,76-83-89-95-98-106-109-117-128-131-142-153-156-165-170-177-185-192,76-83-89-95-98-106-109-117-128-131-142-153-156-165-170-177-185-192,Double blind trial of ASPIRIN in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.",142,98,142,98,-1,152,105,TWrex-cause,804313,"1]  Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris",infarction,aspirin
717919201,5/9/2015 17:11:20,1633271297,5/9/2015 17:11:05,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,13,98-111,Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 17:20:08,1633274933,5/9/2015 17:19:43,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,Melioidosis MELIOIDOSIS,0-13,79-88-98-111-74,gram negative bacillus Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 17:22:19,1633275722,5/9/2015 17:21:27,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,Melioidosis MELIOIDOSIS,0-13,79-88-98-111,negative bacillus Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 17:49:51,1633286246,5/9/2015 17:49:27,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,13,98-111,Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 17:51:51,1633287139,5/9/2015 17:51:14,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,13,111,PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 18:05:11,1633291903,5/9/2015 18:04:41,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,Melioidosis MELIOIDOSIS bacterial pneumonia Burkholderia pseudomallei.,0-13-40-50-98-111,0-13-40-50-79-88-98-111-74,Melioidosis Melioidosis bacterial pneumonia gram negative bacillus Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 18:06:42,1633292414,5/9/2015 18:06:24,false,instagc,1,24252915,GBR,,,80.44.147.241,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,Melioidosis MELIOIDOSIS,0-13,98-111,Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 18:09:55,1633293527,5/9/2015 18:09:42,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,Melioidosis MELIOIDOSIS,0-13,98-111,Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 18:12:07,1633294225,5/9/2015 18:09:58,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,13,79-88-98-111-74,gram negative bacillus Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919201,5/9/2015 18:38:13,1633303720,5/9/2015 18:37:31,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,13,111,,,24,123,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,13,98-111,Burkholderia PSEUDOMALLEI.,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei.,13,111,13,111,1,24,123,TWrex-cause,810810,Melioidosis  Melioidosis is an indolent bacterial pneumonia caused by the gram-negative bacillus  Burkholderia pseudomallei,melioidosis,pseudomalleus
717919202,5/9/2015 19:01:13,1633312654,5/9/2015 19:00:44,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"POLYURIA,",126,3-14-22,"hereditary FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:04:41,1633313846,5/9/2015 19:02:04,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"hereditary Fanconi syndrome, features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA, polydipsia—usually infancy.",3-14-22-51-69-77-87-104-113-126-140-169,3-14-22-51-69-77-87-104-113-126-140-169,"hereditary FANCONI SYNDROME, features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, polydipsia—usually infancy.","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:16:46,1633323887,5/9/2015 19:16:31,false,clixsense,1,24763049,GBR,,,86.137.164.185,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"POLYURIA,",126,14-22,"FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:20:56,1633329572,5/9/2015 19:20:24,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"hypophosphatemic rickets, hypokalemia, POLYURIA, and polydipsia—usually appear in infancy.",87-104-113-126-136-140-159-166-169,0-3-14-22-32-36-42-51-69-77-87-104-113-126-136-140-159-166-169,"In hereditary FANCONI SYNDROME, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:30:31,1633338748,5/9/2015 19:30:16,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"POLYURIA,",126,14-22,"FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:41:31,1633343156,5/9/2015 19:41:04,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"hypophosphatemic rickets, hypokalemia, POLYURIA, and polydipsia—usually appear",87-104-113-126-136-140-159,14-22,"FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:42:58,1633343622,5/9/2015 19:42:10,false,elite,1,30064988,GBR,,,89.241.94.221,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"hypophosphatemic rickets, hypokalemia, POLYURIA,",87-104-113-126,3-14-22,"hereditary FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:43:49,1633343927,5/9/2015 19:43:24,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"POLYURIA,",126,3-14-22,"hereditary FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:47:25,1633345208,5/9/2015 19:46:58,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"POLYURIA,",126,3-14-22,"hereditary FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919202,5/9/2015 19:47:48,1633345342,5/9/2015 19:47:11,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,126,14,,,134,30,POLYURIA,FANCONI SYNDROME,"POLYURIA,",126,14-22,"FANCONI SYNDROME,","In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy.",126,14 22,126,14,1,134,30,TWrex-cause,813317,"In hereditary Fanconi syndrome, the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, polyuria, and polydipsia—usually appear in infancy",polyuria,fanconi syndrome
717919203,5/9/2015 16:11:55,1633247978,5/9/2015 16:11:45,false,clixsense,1,6352682,GBR,H9,London,2.125.111.168,106,66,,,111,76,MANIA,DIVALPROEX,"treatment of bipolar MANIA: a randomized, double",85-95-98-106-113-115-127,50-55-63-66-77-81-85,with lithium or DIVALPROEX for the treatment,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:16:55,1633249923,5/9/2015 16:16:43,false,gifthunterclub,1,30901412,GBR,G5,Margate,85.210.119.8,106,66,,,111,76,MANIA,DIVALPROEX,"Quetiapine lithium divalproex bipolar MANIA: a randomized, double",39-55-98-106-113-115-127-66,50-55-63-66-77-81-85,with lithium or DIVALPROEX for the treatment,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:18:11,1633250480,5/9/2015 16:17:59,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:23:18,1633252137,5/9/2015 16:23:01,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:28:27,1633254372,5/9/2015 16:28:13,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,106-98,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:28:47,1633254481,5/9/2015 16:27:43,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,55-63-66,lithium or DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:32:57,1633256060,5/9/2015 16:32:36,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:39:53,1633258736,5/9/2015 16:39:41,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:45:24,1633260486,5/9/2015 16:44:54,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919203,5/9/2015 16:50:08,1633262165,5/9/2015 16:49:51,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,106,66,,,111,76,MANIA,DIVALPROEX,bipolar MANIA:,98-106,66,DIVALPROEX,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.",106,66,106,66,-1,111,76,TWrex-cause,803448,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study",mania,divalproex
717919204,5/9/2015 17:55:21,1633288429,5/9/2015 17:55:05,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,GIARDIASIS,137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:13:42,1633294792,5/9/2015 18:13:22,false,instagc,1,24252915,GBR,,,80.44.147.241,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,symptomatic GIARDIASIS,125-137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:14:37,1633295218,5/9/2015 18:14:09,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,nitazoxanide metronidazole symptomatic GIARDIASIS,66-125-137-91,48-57-66-91-125-137,clinical study NITAZOXANIDE metronidazole symptomatic giardiasis,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:15:11,1633295462,5/9/2015 18:14:56,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,GIARDIASIS,137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:36:28,1633303068,5/9/2015 18:34:59,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,symptomatic GIARDIASIS,125-137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:49:07,1633308608,5/9/2015 18:48:27,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,GIARDIASIS,137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:52:41,1633309924,5/9/2015 18:52:28,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,symptomatic GIARDIASIS,125-137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:53:06,1633310074,5/9/2015 18:52:50,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,GIARDIASIS,137,66,NITAZOXANIDE,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:53:20,1633310144,5/9/2015 18:52:18,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,nitazoxanide metronidazole treatment symptomatic GIARDIASIS,66-91-112-125-137,66-91-112-125-137,NITAZOXANIDE metronidazole treatment symptomatic giardiasis,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919204,5/9/2015 18:54:21,1633310400,5/9/2015 18:53:26,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,137,66,,,147,78,GIARDIASIS,NITAZOXANIDE,in the treatment of symptomatic GIARDIASIS in children from northern Peru.,105-108-112-122-125-137-148-151-160-165-174,37-48-57-63-66-79-88-91-105-108-112-122-125-137-148-151,Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of symptomatic giardiasis in children,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru.",137,66,137,66,-1,147,78,TWrex-cause,803520,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru",giardiasis,nitazoxanide
717919205,5/9/2015 16:28:14,1633254262,5/9/2015 16:27:50,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58-80-89-74,CYTOMEGALOVIRUS (CMV) specific antibodies,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 16:43:49,1633259947,5/9/2015 16:43:03,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58-80-89-74,CYTOMEGALOVIRUS (CMV) specific antibodies,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 16:55:55,1633265324,5/9/2015 16:55:31,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58-74,CYTOMEGALOVIRUS (CMV),intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 16:57:59,1633266155,5/9/2015 16:57:24,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58,CYTOMEGALOVIRUS,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 17:05:34,1633269314,5/9/2015 17:05:09,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58-80-89,CYTOMEGALOVIRUS specific antibodies,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 17:07:52,1633270241,5/9/2015 17:06:46,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58,CYTOMEGALOVIRUS,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 17:10:53,1633271185,5/9/2015 17:09:54,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,26-35-47-58,globulin preparation containing CYTOMEGALOVIRUS,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 17:32:27,1633279709,5/9/2015 17:31:30,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58,CYTOMEGALOVIRUS,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 17:33:43,1633280229,5/9/2015 17:33:17,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58-80-89,CYTOMEGALOVIRUS specific antibodies,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919205,5/9/2015 17:43:21,1633283845,5/9/2015 17:42:45,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,125,58,,,138,73,CMV INFECTION,CYTOMEGALOVIRUS,CMV INFECTION,125-129,58,CYTOMEGALOVIRUS,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation.,125 129,58,125,58,1,138,73,TWrex-cause,811378,intravenous     An immune globulin preparation containing cytomegalovirus (CMV)-specific antibodies used to treat or prevent CMV infection after organ or tissue transplantation,cmv infection,cytomegalovirus
717919206,5/9/2015 19:37:06,1633341607,5/9/2015 19:36:43,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,78,50,,,90,55,EHRLICHIOSIS,AGENT,granulocytic EHRLICHIOSIS:,65-78,50,AGENT,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 19:53:36,1633347149,5/9/2015 19:53:02,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,78,50,,,90,55,EHRLICHIOSIS,AGENT,granulocytic EHRLICHIOSIS:,65-78,50-59-65-56,AGENT of human granulocytic,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 19:53:48,1633347199,5/9/2015 19:53:22,false,elite,1,30064988,GBR,,,89.241.94.221,78,50,,,90,55,EHRLICHIOSIS,AGENT,human granulocytic EHRLICHIOSIS:,59-65-78,50-56-59-65-78,AGENT of human granulocytic ehrlichiosis:,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 20:06:27,1633351429,5/9/2015 20:05:51,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,78,50,,,90,55,EHRLICHIOSIS,AGENT,of human granulocytic EHRLICHIOSIS:,56-59-65-78,50-56-59-65-78,AGENT of human granulocytic ehrlichiosis:,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 20:10:00,1633352685,5/9/2015 20:08:46,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,78,50,,,90,55,EHRLICHIOSIS,AGENT,human granulocytic EHRLICHIOSIS:,59-65-78,50-56-59-65-78,AGENT of human granulocytic ehrlichiosis:,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 20:50:24,1633366781,5/9/2015 20:50:08,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,78,50,,,90,55,EHRLICHIOSIS,AGENT,granulocytic EHRLICHIOSIS:,65-78,50-56-59-65,AGENT of human granulocytic,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 21:18:01,1633376738,5/9/2015 21:17:46,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,78,50,,,90,55,EHRLICHIOSIS,AGENT,EHRLICHIOSIS:,78,50,AGENT,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 21:25:42,1633379558,5/9/2015 21:25:31,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,78,50,,,90,55,EHRLICHIOSIS,AGENT,granulocytic EHRLICHIOSIS:,65-78,29-33-39-50-56-59-65,the newly cultivated AGENT of human granulocytic,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 22:11:42,1633395981,5/9/2015 22:11:33,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,78,50,,,90,55,EHRLICHIOSIS,AGENT,human granulocytic EHRLICHIOSIS:,59-65-78,50-59-65-78,AGENT human granulocytic ehrlichiosis:,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919206,5/9/2015 22:39:14,1633406741,5/9/2015 22:38:50,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,78,50,,,90,55,EHRLICHIOSIS,AGENT,human granulocytic EHRLICHIOSIS:,59-65-78,33-39-50,newly cultivated AGENT,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.,78,50,78,50,1,90,55,TWrex-cause,810216,Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins,ehrlichiosis,agent
717919207,5/9/2015 18:44:37,1633306541,5/9/2015 18:43:55,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,137,161,,,141,173,PAIN,FIBROMYALGIA,idiopathic PAIN,126-137,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 18:54:39,1633310596,5/9/2015 18:54:05,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,137,161,,,141,173,PAIN,FIBROMYALGIA,PAIN,137,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 18:58:41,1633311921,5/9/2015 18:58:11,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,137,161,,,141,173,PAIN,FIBROMYALGIA,idiopathic PAIN conditions,126-137-142,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 18:59:18,1633312056,5/9/2015 18:58:03,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,137,161,,,141,173,PAIN,FIBROMYALGIA,Chronic pelvic pain trauma stress idiopathic PAIN fibromyalgia.,13-21-28-82-126-137-161-92,13-21-28-82-92-126-137-161,Chronic pelvic pain trauma stress idiopathic pain FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 19:00:03,1633312317,5/9/2015 18:59:15,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,137,161,,,141,173,PAIN,FIBROMYALGIA,idiopathic PAIN conditions,126-137-142,126-142-153-158-161-137,idiopathic pain conditions such as FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 19:15:44,1633322568,5/9/2015 19:15:33,false,clixsense,1,24763049,GBR,,,86.137.164.185,137,161,,,141,173,PAIN,FIBROMYALGIA,PAIN,137,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 19:18:21,1633326010,5/9/2015 19:17:15,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,137,161,,,141,173,PAIN,FIBROMYALGIA,Chronic pelvic pain can overlap with other idiopathic PAIN conditions such as fibromyalgia.,13-21-103-107-115-120-126-137-142-153-158-161-28,13-21-28-61-72-82-103-107-115-120-126-142-153-158-161-137,Chronic pelvic pain generators following trauma can overlap with other idiopathic pain conditions such as FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 19:29:16,1633338329,5/9/2015 19:29:01,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,137,161,,,141,173,PAIN,FIBROMYALGIA,idiopathic PAIN,126-137,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 19:37:59,1633341844,5/9/2015 19:37:14,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,137,161,,,141,173,PAIN,FIBROMYALGIA,idiopathic PAIN,126-137,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919207,5/9/2015 19:40:41,1633342852,5/9/2015 19:40:00,false,elite,1,30064988,GBR,,,89.241.94.221,137,161,,,141,173,PAIN,FIBROMYALGIA,idiopathic PAIN conditions,126-137-142,161,FIBROMYALGIA.,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia.,137,161,137,161,1,141,173,TWrex-cause,814406,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other idiopathic pain conditions such as fibromyalgia,pain,fibromyalgia
717919208,5/9/2015 18:15:02,1633295369,5/9/2015 18:14:39,false,instagc,1,24252915,GBR,,,80.44.147.241,126,103,,,135,112,HEPATITIS,RIBAVIRIN,HEPATITIS C,126-136,103,"RIBAVIRIN,","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:16:17,1633295834,5/9/2015 18:15:37,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,126,103,,,135,112,HEPATITIS,RIBAVIRIN,"Pegylated interferon alfa 2b interferon alfa 2b, ribavirin, HEPATITIS C",37-47-58-78-89-94-103-126-136-63,37-47-58-63-78-89-94-103-118-126-136,"Pegylated interferon alfa 2b interferon alfa 2b, RIBAVIRIN, chronic hepatitis C","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:39:45,1633304278,5/9/2015 18:39:09,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,126,103,,,135,112,HEPATITIS,RIBAVIRIN,chronic HEPATITIS C,118-126-136,103,"RIBAVIRIN,","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:51:29,1633309531,5/9/2015 18:50:38,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,126,103,,,135,112,HEPATITIS,RIBAVIRIN,HEPATITIS C,126-136,103,"RIBAVIRIN,","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:55:59,1633311087,5/9/2015 18:55:13,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,126,103,,,135,112,HEPATITIS,RIBAVIRIN,"Pegylated interferon alfa - 2b standard interferon alfa - 2b, ribavirin, chronic HEPATITIS C HIV - infected",37-47-58-62-63-69-78-89-93-94-103-118-126-136-141-145-144,37-47-58-62-63-69-78-89-93-94-103-118-126-136-141-144-145,"Pegylated interferon alfa - 2b standard interferon alfa - 2b, RIBAVIRIN, chronic hepatitis C HIV - infected","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:56:24,1633311165,5/9/2015 18:55:44,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,126,103,,,135,112,HEPATITIS,RIBAVIRIN,"ribavirin, for chronic HEPATITIS C in HIV infected patients:",103-114-118-126-136-138-141-145-154,37-47-58-63-66-69-78-89-94-98-103-114-118-126-136,"Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN, for chronic hepatitis C","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:57:05,1633311389,5/9/2015 18:54:13,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,126,103,,,135,112,HEPATITIS,RIBAVIRIN,chronic HEPATITIS C,118-126-136,103,"RIBAVIRIN,","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 18:57:11,1633311417,5/9/2015 18:55:10,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,126,103,,,135,112,HEPATITIS,RIBAVIRIN,chronic HEPATITIS C in HIV infected patients:,118-126-136-138-141-145-154,37-47-58-63-66-69-78-89-94-98-103,"Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN,","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 19:14:38,1633321125,5/9/2015 19:14:24,false,clixsense,1,24763049,GBR,,,86.137.164.185,126,103,,,135,112,HEPATITIS,RIBAVIRIN,HEPATITIS,126,103,"RIBAVIRIN,","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919208,5/9/2015 19:15:45,1633322590,5/9/2015 19:14:56,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,126,103,,,135,112,HEPATITIS,RIBAVIRIN,"interferon alfa 2b, plus ribavirin, for chronic HEPATITIS C in HIV infected patients:",78-89-94-98-103-114-118-126-136-138-141-145-154,37-47-58-63-98-103-114-118-126-136-138-141-145-154,"Pegylated interferon alfa 2b plus RIBAVIRIN, for chronic hepatitis C in HIV infected patients:","Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.",126,103,126,103,-1,135,112,TWrex-cause,800135,"Carrat F, Bani-Sadr F, Pol S, et al: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial",hepatitis,ribavirin
717919209,5/9/2015 19:04:13,1633313733,5/9/2015 19:04:00,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,72,PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:19:25,1633327436,5/9/2015 19:18:58,false,clixsense,1,24763049,GBR,,,86.137.164.185,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,72,PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:33:20,1633339939,5/9/2015 19:33:09,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,72,PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:46:59,1633345063,5/9/2015 19:46:42,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,49-62-69-72,hypertension caused by PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:47:02,1633345082,5/9/2015 19:46:47,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,72,PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:47:20,1633345167,5/9/2015 19:46:58,false,elite,1,30064988,GBR,,,89.241.94.221,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION caused by pheochromocytoma.,49-62-69-72,49-62-69-72,hypertension caused by PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:52:09,1633346670,5/9/2015 19:51:48,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,72,PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 19:54:13,1633347354,5/9/2015 19:53:28,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION caused by pheochromocytoma.,49-69-72-62,49-62-69-72,hypertension caused by PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 20:14:02,1633354201,5/9/2015 20:13:52,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,72,PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919209,5/9/2015 20:18:12,1633355728,5/9/2015 20:17:51,false,instagc,1,21467491,USA,PA,Erie,107.9.206.78,49,72,,,61,88,HYPERTENSION,PHEOCHROMOCYTOMA,the management of HYPERTENSION caused by pheochromocytoma.,31-35-46-49-62-69-72,35-49-62-69-72-46,management of hypertension caused by PHEOCHROMOCYTOMA.,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma.,49,72,49,72,1,61,88,TWrex-cause,813053,b  Diazoxide is ineffective in the management of hypertension caused by pheochromocytoma,hypertension,pheochromocytoma
717919210,5/9/2015 20:54:31,1633368241,5/9/2015 20:54:07,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION,45,0,ACEBUTOLOL,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/9/2015 21:28:59,1633380701,5/9/2015 21:28:44,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION and renal functional,45-58-62-68,0,ACEBUTOLOL,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/9/2015 22:14:19,1633396921,5/9/2015 22:14:08,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION renal functional,45-62-68,0-45,ACEBUTOLOL hypertension,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/9/2015 22:43:21,1633408567,5/9/2015 22:43:09,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION,45,0,ACEBUTOLOL,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/9/2015 23:48:23,1633436980,5/9/2015 23:48:00,false,neodev,1,31139768,USA,DE,,108.59.10.153,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,Acebutolol treatment patients HYPERTENSION renal functional impairment.,0-18-31-45-62-68-79,0-11-14-18-28-31-45,ACEBUTOLOL in the treatment of patients hypertension,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/10/2015 00:18:10,1633450985,5/10/2015 00:17:56,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION,45,0,ACEBUTOLOL,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/10/2015 00:49:17,1633461407,5/10/2015 00:49:01,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION,45,0,ACEBUTOLOL,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/10/2015 00:59:03,1633464774,5/10/2015 00:57:53,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION,45,0-11-14-18-28-31-45-58-62-68-79-40,ACEBUTOLOL in the treatment of patients with hypertension and renal functional impairment.,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/10/2015 01:00:39,1633465167,5/10/2015 01:00:30,false,elite,1,31848723,USA,,,155.94.185.225,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,of patients with HYPERTENSION and renal functional,28-31-40-45-58-62-68,0-11-14-18,ACEBUTOLOL in the treatment,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919210,5/10/2015 01:52:46,1633482811,5/10/2015 01:52:30,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,45,0,,,57,10,HYPERTENSION,ACEBUTOLOL,HYPERTENSION,45,0,ACEBUTOLOL,Acebutolol in the treatment of patients with hypertension and renal functional impairment.,45,0,45,0,-1,57,10,TWrex-cause,803835,Acebutolol in the treatment of patients with hypertension and renal functional impairment,hypertension,acebutolol
717919211,5/9/2015 19:21:18,1633330066,5/9/2015 19:21:03,false,clixsense,1,24763049,GBR,,,86.137.164.185,154,202,,,156,204,MD,VA,MD;,154,202,VA;,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 19:35:03,1633340685,5/9/2015 19:34:41,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,154,202,,,156,204,MD,VA,MD;,154,202,VA;,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 19:50:06,1633346066,5/9/2015 19:49:26,false,elite,1,30064988,GBR,,,89.241.94.221,154,202,,,156,204,MD,VA,"Transplantation, Rockville, MD; United Network",126-143-154-158-165,177-183-192-202-206-212-221,"Organ Sharing, Richmond, VA; Arbor Research Collaborative","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 19:50:11,1633346068,5/9/2015 19:49:21,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,154,202,,,156,204,MD,VA,"Transplantation, Rockville, MD;",126-143-154,177-183-192-202,"Organ Sharing, Richmond, VA;","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 19:55:37,1633347800,5/9/2015 19:54:22,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,154,202,,,156,204,MD,VA,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD;",0-11-14-21-25-31-41-48-58-62-71-87-98-106-114-123-126-154-143,177-183-192-202-206-212-221-235-239,"Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health,","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 20:02:17,1633349850,5/9/2015 20:01:48,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,154,202,,,156,204,MD,VA,"Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA;",114-123-126-143-154-158-165-173-177-183-192-202,177-183-192-202-206-212-221,"Organ Sharing, Richmond, VA; Arbor Research Collaborative","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 20:47:36,1633365844,5/9/2015 20:46:50,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,154,202,,,156,204,MD,VA,"Transplantation, MD;",126-154,177-183-202,"Organ Sharing, VA;","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 21:16:00,1633375967,5/9/2015 21:14:59,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,154,202,,,156,204,MD,VA,MD;,154,202,VA;,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 21:22:07,1633378376,5/9/2015 21:21:42,false,elite,1,32601739,GBR,H4,Leicester,89.243.105.120,154,202,,,156,204,MD,VA,"Rockville, MD;",154-143,192-202,"Richmond, VA;","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919211,5/9/2015 21:22:48,1633378589,5/9/2015 21:22:21,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,154,202,,,156,204,MD,VA,"Transplantation, Rockville, MD;",126-143-154,87-177-183-192-202,"Healthcare Organ Sharing, Richmond, VA;","Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6.",154,202,154,202,-1,156,204,TWrex-cause,800576,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI. [ Full Text ]  6",MD,VA
717919212,5/9/2015 16:53:03,1633263644,5/9/2015 16:52:26,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA Crisis,5-15-28,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 17:04:19,1633268866,5/9/2015 17:03:38,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA Crisis,5-15-28,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 17:10:21,1633271022,5/9/2015 17:10:00,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA,5-15,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 17:17:42,1633273951,5/9/2015 17:17:04,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA Crisis,5-15-28,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 17:18:56,1633274494,5/9/2015 17:18:42,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,109 MALIGNANT HYPERTHERMIA Crisis,0-5-15-28,51-63-67-78,discontinue all anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 17:48:50,1633285833,5/9/2015 17:47:23,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA,5-15,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 17:50:12,1633286365,5/9/2015 17:49:42,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA,5-15,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 18:02:59,1633291079,5/9/2015 18:02:22,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA anesthetic agents IV dantrolene malignant hyperthermia,5-15-67-78-99-102-124-134,5-15-67-78-99-102-124-134-28,Malignant Hyperthermia Crisis anesthetic AGENTS IV dantrolene malignant hyperthermia,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 18:05:21,1633291966,5/9/2015 18:05:03,false,instagc,1,24252915,GBR,,,80.44.147.241,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA Crisis,5-15-28,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919212,5/9/2015 18:09:04,1633293256,5/9/2015 18:08:38,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,5,78,,,27,84,MALIGNANT HYPERTHERMIA,AGENT,MALIGNANT HYPERTHERMIA,5-15,67-78,anesthetic AGENTS,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized.,5 15,78,5,78,1,27,84,TWrex-cause,811489,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all anesthetic agents and institute IV dantrolene as soon as malignant hyperthermia crisis is recognized,malignant hyperthermia,agent
717919213,5/9/2015 18:42:28,1633305529,5/9/2015 18:41:11,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,93,62,,,97,69,PAIN,ASPIRIN,postpartum uterine PAIN.,74-85-93,62,ASPIRIN,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 18:53:37,1633310180,5/9/2015 18:52:13,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,93,62,,,97,69,PAIN,ASPIRIN,PAIN.,93,62,ASPIRIN,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 18:57:14,1633311420,5/9/2015 18:57:05,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,93,62,,,97,69,PAIN,ASPIRIN,Ketorolac versus aspirin for postpartum uterine PAIN.,45-55-70-74-85-93-62,45-55-62-70-74-85-93,Ketorolac versus ASPIRIN for postpartum uterine pain.,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 18:57:25,1633311461,5/9/2015 18:57:00,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,93,62,,,97,69,PAIN,ASPIRIN,Ketorolac aspirin postpartum uterine PAIN.,62-74-85-93-45,45-62-74-85-93,Ketorolac ASPIRIN postpartum uterine pain.,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 18:57:52,1633311685,5/9/2015 18:57:40,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,93,62,,,97,69,PAIN,ASPIRIN,postpartum uterine PAIN.,74-85-93,62,ASPIRIN,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 18:59:00,1633312007,5/9/2015 18:58:50,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,93,62,,,97,69,PAIN,ASPIRIN,postpartum uterine PAIN.,74-85-93,62-70-74-85-93,ASPIRIN for postpartum uterine pain.,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 19:15:20,1633322024,5/9/2015 19:15:07,false,clixsense,1,24763049,GBR,,,86.137.164.185,93,62,,,97,69,PAIN,ASPIRIN,PAIN.,93,62,ASPIRIN,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 19:16:39,1633323733,5/9/2015 19:16:29,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,93,62,,,97,69,PAIN,ASPIRIN,Ketorolac versus aspirin for postpartum uterine PAIN.,45-55-70-74-85-93-62,45-55-62-70-74-85-93,Ketorolac versus ASPIRIN for postpartum uterine pain.,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 19:28:45,1633338133,5/9/2015 19:28:28,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,93,62,,,97,69,PAIN,ASPIRIN,PAIN.,93,62,ASPIRIN,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919213,5/9/2015 19:36:25,1633341308,5/9/2015 19:35:49,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,93,62,,,97,69,PAIN,ASPIRIN,postpartum uterine PAIN.,74-85-93,45-55-62,Ketorolac versus ASPIRIN,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain.",93,62,93,62,-1,97,69,TWrex-cause,800885,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus aspirin for postpartum uterine pain",pain,aspirin
717919214,5/9/2015 16:27:10,1633253862,5/9/2015 16:26:50,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA,",218-230-236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 16:40:41,1633258992,5/9/2015 16:40:03,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA,",218-230-236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 16:55:00,1633264819,5/9/2015 16:54:24,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA,",218-230-236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 16:56:06,1633265376,5/9/2015 16:55:16,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"DYSTONIA,",236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 17:03:38,1633268572,5/9/2015 17:03:05,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA,",218-230-236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 17:04:27,1633268941,5/9/2015 17:03:45,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA,",218-230-236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 17:06:35,1633269754,5/9/2015 17:05:27,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"axial DYSTONIA, pseudobulbar palsy,",230-236-246-259,40-51-61-72-84-97,Richardson Olszewski Syndrome) PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 17:21:34,1633275427,5/9/2015 17:19:32,false,quickrewards,1,8672587,USA,TX,El Paso,209.194.208.150,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA, pseudobulbar palsy, dementia.",218-230-236-246-259-270,40-51-61-72-84-97-32,(Steele Richardson Olszewski Syndrome) PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 17:26:34,1633277450,5/9/2015 17:26:15,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"DYSTONIA,",236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919214,5/9/2015 17:32:39,1633279782,5/9/2015 17:31:59,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,236,72,,,244,102,DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY,"progressive axial DYSTONIA,",218-230-236,72-84-97,PROGRESSIVE SUPRANUCLEAR PALSY,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia.",236,72 84 97,236,72,1,244,102,TWrex-cause,814006,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele-Richardson-Olszewski Syndrome)  Progressive supranuclear palsy is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with progressive axial dystonia, pseudobulbar palsy, and dementia",dystonia,progressive supranuclear palsy
717919215,5/9/2015 16:26:23,1633253506,5/9/2015 16:26:09,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 16:38:54,1633258500,5/9/2015 16:38:18,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 16:52:46,1633263534,5/9/2015 16:52:11,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 16:53:59,1633264321,5/9/2015 16:53:43,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 16:57:53,1633266138,5/9/2015 16:57:34,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 16:58:24,1633266300,5/9/2015 16:57:42,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,126,67,,,130,69,PAIN,FM,"individuals who attribute their FM to trauma have more perceived disability, self reported PAIN, life interference, and affective distress than patients with idiopathic onset.",35-47-51-61-67-70-73-80-85-90-100-112-117-126-132-137-151-155-165-174-179-188-193-204,35-47-51-61-67-70-73-80-85-90-100-112-117-126-132-137-151-155-165-174-179-188-193-204,"individuals who attribute their FM to trauma have more perceived disability, self reported pain, life interference, and affective distress than patients with idiopathic onset.","25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 17:02:14,1633268037,5/9/2015 17:01:31,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 17:04:05,1633268776,5/9/2015 17:02:44,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,126,67,,,130,69,PAIN,FM,"disability, self reported PAIN,",100-112-117-126,51-61-67,attribute their FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 17:04:13,1633268827,5/9/2015 17:04:01,false,superrewards,1,31767535,GBR,V2,Glasgow,90.198.84.40,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919215,5/9/2015 17:14:02,1633272350,5/9/2015 17:13:48,false,zoombucks,1,4688131,CAN,BC,Vancouver,75.156.91.114,126,67,,,130,69,PAIN,FM,"PAIN,",126,67,FM,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset.",126,67,126,67,1,130,69,TWrex-cause,812634,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self-reported pain, life interference, and affective distress than patients with idiopathic onset",pain,FM
717919216,5/9/2015 18:14:38,1633295228,5/9/2015 18:14:23,false,instagc,1,24252915,GBR,,,80.44.147.241,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA,0,19-30,PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:15:36,1633295615,5/9/2015 18:15:22,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA Plasmodium falciparum.,0-19-30,0-19-30,Malaria PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:15:55,1633295738,5/9/2015 18:15:46,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA,0,19-30,PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:39:04,1633303967,5/9/2015 18:38:10,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA,0,19-30,PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:50:37,1633309199,5/9/2015 18:50:01,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA,0,19-30,PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:54:12,1633310341,5/9/2015 18:54:00,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA,0,19-30,PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:55:09,1633310792,5/9/2015 18:54:31,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA caused by Plasmodium falciparum.,0-8-15-19-30,0-8-15-19-30,Malaria caused by PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:55:10,1633310798,5/9/2015 18:54:28,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA Plasmodium falciparum.,0-19-30,0-19-30,Malaria PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 18:55:43,1633310977,5/9/2015 18:55:30,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA caused by Plasmodium falciparum.,0-8-15-19-30,0-8-15-19-30,Malaria caused by PLASMODIUM falciparum.,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919216,5/9/2015 19:14:23,1633320725,5/9/2015 19:14:13,false,clixsense,1,24763049,GBR,,,86.137.164.185,0,19,,,7,29,MALARIA,PLASMODIUM,MALARIA,0,19,PLASMODIUM,Malaria caused by  Plasmodium falciparum.,0,19,0,19,1,7,29,TWrex-cause,810964,Malaria caused by  Plasmodium falciparum,malaria,plasmodium
717919217,5/9/2015 18:41:06,1633304902,5/9/2015 18:40:24,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS.,90-97,39,OMEPRAZOLE,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 18:52:12,1633309758,5/9/2015 18:51:44,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS.,90-97,39,OMEPRAZOLE,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 18:56:58,1633311358,5/9/2015 18:56:30,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,Omeprazole ranitidine long - term treatment reflux ESOPHAGITIS.,39-53-67-71-72-77-97-90,39-53-67-71-72-77-90-97,OMEPRAZOLE ranitidine long - term treatment reflux esophagitis.,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 18:57:04,1633311387,5/9/2015 18:56:46,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,Omeprazole or ranitidine in long term treatment of reflux ESOPHAGITIS.,39-50-53-64-67-77-87-90-97-72,39-50-53-64-67-72-77-87-90-97,OMEPRAZOLE or ranitidine in long term treatment of reflux esophagitis.,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 18:57:40,1633311612,5/9/2015 18:57:25,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS.,90-97,39,OMEPRAZOLE,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 18:58:49,1633311938,5/9/2015 18:57:50,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS.,90-97,39-50-53,OMEPRAZOLE or ranitidine,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 19:15:06,1633321694,5/9/2015 19:14:54,false,clixsense,1,24763049,GBR,,,86.137.164.185,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,97,39,OMEPRAZOLE,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 19:16:28,1633323454,5/9/2015 19:16:06,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,Omeprazole or ranitidine in long term treatment of reflux ESOPHAGITIS.,39-50-53-64-67-77-87-90-97-72,39-50-53-64-67-72-77-87-90-97,OMEPRAZOLE or ranitidine in long term treatment of reflux esophagitis.,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 19:28:26,1633338066,5/9/2015 19:28:07,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS.,90-97,39,OMEPRAZOLE,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919217,5/9/2015 19:35:48,1633341050,5/9/2015 19:34:00,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,97,39,,,108,49,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS.,90-97,39-50-53,OMEPRAZOLE or ranitidine,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis.",97,39,97,39,-1,108,49,TWrex-cause,804104,"Hallerback B, Unge P, Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis",esophagitis,omeprazole
717919218,5/9/2015 16:29:37,1633254821,5/9/2015 16:29:24,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 16:48:26,1633261570,5/9/2015 16:47:34,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 16:58:24,1633266296,5/9/2015 16:57:48,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,85-90-101-108-111,high hematocrit levels in PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:00:54,1633267275,5/9/2015 17:00:26,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:08:06,1633270314,5/9/2015 17:07:35,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:12:41,1633271760,5/9/2015 17:11:58,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:15:24,1633272995,5/9/2015 17:14:03,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,166,111,,,176,113,HEMORRHAGE,PV,thrombosis and HEMORRHAGE,151-162-166,90-101-108-111,hematocrit levels in PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:34:36,1633280609,5/9/2015 17:34:20,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,166,111,,,176,113,HEMORRHAGE,PV,thrombosis HEMORRHAGE,151-166,90-101-111,hematocrit levels PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:45:14,1633284465,5/9/2015 17:44:57,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919218,5/9/2015 17:46:31,1633284863,5/9/2015 17:45:33,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,166,111,,,176,113,HEMORRHAGE,PV,HEMORRHAGE,166,111,PV,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31.,166,111,166,111,1,176,113,TWrex-cause,814641,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and hemorrhage ( 29 ;  30 ;  31,hemorrhage,pv
717919219,5/9/2015 19:36:23,1633341277,5/9/2015 19:36:10,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA,",0-7,99-107,CROHN'S DISEASE),"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 19:52:22,1633346795,5/9/2015 19:52:01,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"DIARRHEA, fever,",7-17,78-90-99-107,"(ulcerative colitis, CROHN'S DISEASE)","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 19:52:54,1633346929,5/9/2015 19:52:27,false,elite,1,30064988,GBR,,,89.241.94.221,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA, fever, and abdominal pain",0-7-17-24-28-38,51-64-70-78-90-99-107-122-133,"inflammatory bowel disease (ulcerative colitis, CROHN'S DISEASE) infectious colitis","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 20:01:02,1633349550,5/9/2015 20:00:43,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA,",0-7,99-107,CROHN'S DISEASE),"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 20:05:27,1633351108,5/9/2015 20:04:29,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"DIARRHEA,",7,70-78-90-99-107-116-119-122-133,"disease (ulcerative colitis, CROHN'S DISEASE) or an infectious colitis","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 20:49:39,1633366553,5/9/2015 20:49:23,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA,",0-7,78-90-99-107,"(ulcerative colitis, CROHN'S DISEASE)","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 21:17:25,1633376526,5/9/2015 21:17:08,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA,",0-7,78-90-99-107,"(ulcerative colitis, CROHN'S DISEASE)","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 21:25:05,1633379393,5/9/2015 21:24:47,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA,",0-7,78-90-99-107,"(ulcerative colitis, CROHN'S DISEASE)","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 22:11:17,1633395880,5/9/2015 22:11:06,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"DIARRHEA,",7,90-99-107-78,"(ulcerative colitis, CROHN'S DISEASE)","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919219,5/9/2015 22:37:58,1633406363,5/9/2015 22:35:27,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,7,99,,,15,114,DIARRHEA,CROHN'S DISEASE,"Bloody DIARRHEA,",0-7,51-64-78-90-99-107-70,"inflammatory bowel disease (ulcerative colitis, CROHN'S DISEASE)","Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",7,99 107,7,99,1,15,114,TWrex-cause,812921,"Bloody diarrhea, fever, and abdominal pain suggest inflammatory bowel disease (ulcerative colitis, Crohn's disease) or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis",diarrhea,crohn's disease
717919220,5/9/2015 16:51:29,1633262744,5/9/2015 16:50:47,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,chronic lymphocytic LEUKEMIA.,120-128-140,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:03:01,1633268359,5/9/2015 17:02:17,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,B cell chronic lymphocytic LEUKEMIA.,115-120-128-140-113,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:09:33,1633270802,5/9/2015 17:09:10,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,B cell chronic lymphocytic LEUKEMIA.,115-120-128-140-113,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:15:27,1633273010,5/9/2015 17:14:53,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,B cell chronic lymphocytic LEUKEMIA.,115-120-128-140-113,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:17:48,1633274006,5/9/2015 17:16:57,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,cell chronic lymphocytic LEUKEMIA.,115-120-128-140,48-53-62-71,drug approval summary: ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:35:35,1633280984,5/9/2015 17:35:26,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,cell chronic lymphocytic LEUKEMIA.,115-120-128-140,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:46:54,1633285012,5/9/2015 17:46:29,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,B cell chronic lymphocytic LEUKEMIA.,115-120-128-140-113,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 17:49:11,1633286013,5/9/2015 17:48:44,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,LEUKEMIA.,140,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 18:01:41,1633290606,5/9/2015 18:01:11,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,alemtuzumab lymphocytic LEUKEMIA.,71-128-140,71-120-128-140,ALEMTUZUMAB chronic lymphocytic leukemia.,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919220,5/9/2015 18:04:42,1633291733,5/9/2015 18:04:17,false,instagc,1,24252915,GBR,,,80.44.147.241,140,71,,,148,82,LEUKEMIA,ALEMTUZUMAB,B - cell chronic lymphocytic LEUKEMIA.,113-114-120-128-140-115,71,ALEMTUZUMAB,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.",140,71,140,71,-1,148,82,TWrex-cause,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia",leukemia,alemtuzumab
717919221,5/9/2015 16:27:49,1633254097,5/9/2015 16:27:34,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER: a,48-62-69-90,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 16:43:02,1633259689,5/9/2015 16:41:26,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 16:55:30,1633265151,5/9/2015 16:55:15,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 16:57:23,1633265927,5/9/2015 16:56:39,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 17:05:08,1633269153,5/9/2015 17:04:49,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER: a,48-62-69-90,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 17:06:44,1633269837,5/9/2015 17:05:16,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 17:09:52,1633270947,5/9/2015 17:08:37,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,0-9-12,Efficacy of SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 17:31:29,1633279267,5/9/2015 17:31:07,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 17:33:16,1633280038,5/9/2015 17:33:00,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919221,5/9/2015 17:42:44,1633283516,5/9/2015 17:42:20,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,48,12,,,77,22,POSTTRAUMATIC STRESS DISORDER,SERTRALINE,POSTTRAUMATIC STRESS DISORDER:,48-62-69,12,SERTRALINE,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.",48 62 69,12,48,12,-1,77,22,TWrex-cause,804721,"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study",posttraumatic stress disorder,sertraline
717919222,5/9/2015 19:21:50,1633330745,5/9/2015 19:21:32,false,clixsense,1,24763049,GBR,,,86.137.164.185,59,23,,,61,34,MI,CLOPIDOGREL,"MI,",59,23,CLOPIDOGREL,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 19:35:36,1633340918,5/9/2015 19:35:18,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,59,23,,,61,34,MI,CLOPIDOGREL,"MI,",59,23,CLOPIDOGREL,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 19:50:52,1633346309,5/9/2015 19:50:31,false,elite,1,30064988,GBR,,,89.241.94.221,59,23,,,61,34,MI,CLOPIDOGREL,"MI, and stroke",59-63-67,14-23,"aspirin, CLOPIDOGREL","When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 19:51:14,1633346440,5/9/2015 19:50:42,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,59,23,,,61,34,MI,CLOPIDOGREL,"MI, and stroke",59-63-67,14-23,"aspirin, CLOPIDOGREL","When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 19:56:34,1633348121,5/9/2015 19:56:12,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,59,23,,,61,34,MI,CLOPIDOGREL,"MI,",59,23,CLOPIDOGREL,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 20:03:31,1633350365,5/9/2015 20:02:38,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,59,23,,,61,34,MI,CLOPIDOGREL,"risk for death, MI, and stroke after an acute coronary syndrome (1) or percutaneous coronary intervention",43-48-52-59-63-67-74-80-83-89-98-108-113-116-129-138,5-11-14-23-35-43-48-52,"added to aspirin, CLOPIDOGREL reduces risk for death,","When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 20:48:21,1633366097,5/9/2015 20:48:03,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,59,23,,,61,34,MI,CLOPIDOGREL,"MI,",59,23,CLOPIDOGREL,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 21:16:31,1633376184,5/9/2015 21:16:14,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,59,23,,,61,34,MI,CLOPIDOGREL,"MI,",59,23,CLOPIDOGREL,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 21:23:27,1633378856,5/9/2015 21:23:04,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,59,23,,,61,34,MI,CLOPIDOGREL,"MI, and stroke after",59-63-67-74,23-35-43-48,CLOPIDOGREL reduces risk for,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919222,5/9/2015 21:32:19,1633382013,5/9/2015 21:30:29,false,instagc,1,31861996,USA,FL,Homestead,73.46.199.178,59,23,,,61,34,MI,CLOPIDOGREL,"risk for death, MI, and stroke after",43-48-52-59-63-67-74,5-11-14-23-35-43-48,"added to aspirin, CLOPIDOGREL reduces risk for","When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",59,23,59,23,-1,61,34,TWrex-cause,800853,"When added to aspirin, clopidogrel reduces risk for death, MI, and stroke after an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2)",mi,clopidogrel
717919223,5/9/2015 16:26:09,1633253411,5/9/2015 16:25:50,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 16:38:17,1633258277,5/9/2015 16:36:53,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 16:52:09,1633263147,5/9/2015 16:51:39,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 16:53:42,1633264083,5/9/2015 16:53:06,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 16:57:32,1633265991,5/9/2015 16:57:12,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,46-49-59-66,W. MEROPENEM versus ceftazidime,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 16:57:41,1633266063,5/9/2015 16:57:03,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,127,49,,,138,58,NEUTROPENIA,MEROPENEM,"Meropenem versus ceftazidime in the treatment of cancer patients with febrile NEUTROPENIA: a randomized, double blind trial.",49-59-66-78-81-85-95-98-105-114-119-127-140-142-154-161-167,49-59-66-78-81-85-95-98-105-114-119-127-140-142-154-161-167,"MEROPENEM versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double blind trial.","1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 17:01:30,1633267590,5/9/2015 17:00:43,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 17:02:42,1633268196,5/9/2015 17:02:00,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,127,49,,,138,58,NEUTROPENIA,MEROPENEM,NEUTROPENIA:,127,40-43-46-49-59-66,"A, Ho W. MEROPENEM versus ceftazidime","1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 17:03:59,1633268749,5/9/2015 17:03:41,false,superrewards,1,31767535,GBR,V2,Glasgow,90.198.84.40,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919223,5/9/2015 17:13:47,1633272159,5/9/2015 17:13:31,false,zoombucks,1,4688131,CAN,BC,Vancouver,75.156.91.114,127,49,,,138,58,NEUTROPENIA,MEROPENEM,febrile NEUTROPENIA:,119-127,49,MEROPENEM,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.",127,49,127,49,-1,138,58,TWrex-cause,800068,"1]  Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial",neutropenia,meropenem
717919224,5/9/2015 16:29:23,1633254762,5/9/2015 16:29:10,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 16:47:33,1633261265,5/9/2015 16:46:51,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 16:57:48,1633266078,5/9/2015 16:57:26,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:00:25,1633267067,5/9/2015 17:00:00,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:07:32,1633270123,5/9/2015 17:07:11,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION, retinitis",53-60-73,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:11:55,1633271462,5/9/2015 17:11:18,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:14:02,1633272347,5/9/2015 17:12:48,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:34:19,1633280455,5/9/2015 17:34:07,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION, retinitis pigmentosa,",53-60-73-83,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:35:39,1633281016,5/9/2015 17:35:23,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919224,5/9/2015 17:44:55,1633284367,5/9/2015 17:44:39,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,53,0,,,71,22,MENTAL RETARDATION,LAURENCE MOON SYNDROME,"MENTAL RETARDATION,",53-60,0-9-14,LAURENCE MOON SYNDROME,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly.",53 60,0 9 14,53,0,1,71,22,TWrex-cause,812898,"Laurence-Moon syndrome  is characterized by obesity, mental retardation, retinitis pigmentosa, and polydactyly",mental retardation,laurence moon syndrome
717919225,5/9/2015 20:53:33,1633367908,5/9/2015 20:53:11,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME Diagnoses,104-107-116-129-138-158,43-46-65-68,; hypofibrinogenemia ; SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/9/2015 21:28:29,1633380510,5/9/2015 21:28:10,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME Nursing Diagnoses Appendix.,107-116-129-138-150-158-168,68,SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/9/2015 22:13:50,1633396772,5/9/2015 22:13:28,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,104-107-116-129-138,43-46-65-68,; hypofibrinogenemia ; SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/9/2015 22:42:52,1633408338,5/9/2015 22:42:24,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME Nursing,107-116-129-138-150,68,SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/9/2015 23:47:32,1633436550,5/9/2015 23:47:06,false,neodev,1,31139768,USA,DE,,108.59.10.153,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME Nursing Diagnoses Appendix.,107-116-129-138-150-158-168,46-68-78-85-94,hypofibrinogenemia SEPSIS serine protease inhibitor,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/10/2015 00:17:40,1633450756,5/10/2015 00:17:25,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,107-116-129-138,68,SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/10/2015 00:35:58,1633457307,5/10/2015 00:35:19,false,neodev,1,20233773,USA,CA,San Jose,50.118.172.32,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME Appendix.,104-107-116-129-138-168,46-65-68-168,hypofibrinogenemia ; SEPSIS Appendix.,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/10/2015 00:48:28,1633461061,5/10/2015 00:47:59,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,104-107-116-129-138,68,SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/10/2015 00:55:23,1633463576,5/10/2015 00:53:58,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,104-107-116-129-138,68,SEPSIS,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919225,5/10/2015 01:00:16,1633465056,5/10/2015 00:59:52,false,elite,1,31848723,USA,,,155.94.185.225,107,68,,,146,74,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,protease inhibitor ; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME Nursing Appendix.,85-94-104-107-116-129-138-150-168,43-46-65-68-78-85-94,; hypofibrinogenemia ; SEPSIS serine protease inhibitor,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix.,107 116 129 138,68,107,68,1,146,74,TWrex-cause,814240,SEE:   acute respiratory distress syndrome ;  hypofibrinogenemia ;  sepsis ;  serine protease inhibitor ;  systemic inflammatory response syndrome ;  Nursing Diagnoses Appendix,systemic inflammatory response syndrome,sepsis
717919226,5/9/2015 17:52:33,1633287420,5/9/2015 17:52:09,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN,35,56,ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 17:57:05,1633289152,5/9/2015 17:56:40,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN,35,56,ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:10:17,1633293650,5/9/2015 18:09:52,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,35,56,,,39,69,PAIN,ENDOMETRIOSIS,LNG IUS PAIN endometriosis.,17-21-35-56,17-21-35-56,LNG IUS pain ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:10:56,1633293796,5/9/2015 18:10:43,false,instagc,1,24252915,GBR,,,80.44.147.241,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN,35,56,ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:12:54,1633294462,5/9/2015 18:12:42,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN,35,56,ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:25:31,1633299377,5/9/2015 18:24:30,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN associated with endometriosis.,35-51-56-40,56,ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:44:26,1633306467,5/9/2015 18:44:17,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN associated with endometriosis.,35-40-51-56,35-40-51-56,pain associated with ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:44:57,1633306734,5/9/2015 18:42:45,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,35,56,,,39,69,PAIN,ENDOMETRIOSIS,PAIN,35,56,ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:47:42,1633308018,5/9/2015 18:47:13,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,35,56,,,39,69,PAIN,ENDOMETRIOSIS,LNG IUS PAIN endometriosis.,21-35-56-17,17-35-51-56-21,LNG IUS pain with ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919226,5/9/2015 18:49:29,1633308786,5/9/2015 18:49:06,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,35,56,,,39,69,PAIN,ENDOMETRIOSIS,LNG IUS to reduce PAIN associated with endometriosis.,21-25-28-35-40-51-56-17,17-21-25-35-40-51-56-28,LNG IUS to reduce pain associated with ENDOMETRIOSIS.,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis.,35,56,35,56,1,39,69,TWrex-cause,812862,7.4 Consider the LNG-IUS to reduce pain associated with endometriosis,pain,endometriosis
717919227,5/9/2015 17:53:36,1633287840,5/9/2015 17:53:10,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,55-72-75,Pharmacokinetics of TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 17:59:02,1633289813,5/9/2015 17:58:33,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,75,TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:11:44,1633294080,5/9/2015 18:11:18,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,117,75,,,122,86,TINEA,TERBINAFINE,Pharmacokinetics terbinafine TINEA capitis.,55-117-123-75,55-72-75-87-90-96-117-123,Pharmacokinetics of TERBINAFINE in young children tinea capitis.,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:11:54,1633294145,5/9/2015 18:11:33,false,instagc,1,24252915,GBR,,,80.44.147.241,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,75,TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:13:48,1633294844,5/9/2015 18:13:36,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,75,TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:29:28,1633300764,5/9/2015 18:28:46,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,55-72-75,Pharmacokinetics of TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:46:05,1633307377,5/9/2015 18:45:51,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,75,TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:49:21,1633308712,5/9/2015 18:48:50,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,117,75,,,122,86,TINEA,TERBINAFINE,terbinafine TINEA capitis.,75-117-123,55-75-117-123,Pharmacokinetics TERBINAFINE tinea capitis.,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:50:37,1633309207,5/9/2015 18:50:14,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,117,75,,,122,86,TINEA,TERBINAFINE,Pharmacokinetics of terbinafine in young children treated for TINEA capitis.,55-72-75-87-96-105-113-117-123-90,55-72-75-87-90-96-105-113-117-123,Pharmacokinetics of TERBINAFINE in young children treated for tinea capitis.,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919227,5/9/2015 18:50:54,1633309362,5/9/2015 18:50:32,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,117,75,,,122,86,TINEA,TERBINAFINE,TINEA capitis.,117-123,55-72-75,Pharmacokinetics of TERBINAFINE,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis.",117,75,117,75,-1,122,86,TWrex-cause,803551,"Abdel-Rahman SM, Herron J, Fallon-Friedlander S et al. Pharmacokinetics of terbinafine in young children treated for tinea capitis",tinea,terbinafine
717919228,5/9/2015 17:26:01,1633277244,5/9/2015 17:24:11,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 17:50:46,1633286570,5/9/2015 17:50:31,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,7-13-0,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 17:53:52,1633287939,5/9/2015 17:53:16,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:07:23,1633292670,5/9/2015 18:06:43,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE abnormality mitral regurgitation Marfan syndrome atrial septal defect.,0-7-13-45-86-93-128-135-150-157-164,0-7-13-36-45-86-128-135-150-157-164-93,Mitral valve prolapse isolated abnormality mitral regurgitation MARFAN SYNDROME atrial septal defect.,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:08:06,1633292916,5/9/2015 18:07:40,false,instagc,1,24252915,GBR,,,80.44.147.241,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:11:04,1633293851,5/9/2015 18:10:28,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:17:27,1633296319,5/9/2015 18:16:28,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:39:22,1633304091,5/9/2015 18:38:58,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:42:03,1633305353,5/9/2015 18:41:43,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,PROLAPSE abnormality,13-45,86-128-135-93,mitral regurgitation MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919228,5/9/2015 18:43:09,1633305799,5/9/2015 18:42:57,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,13,128,,,21,143,PROLAPSE,MARFAN SYNDROME,Mitral valve PROLAPSE,0-7-13,128-135,MARFAN SYNDROME,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect.,13,128 135,13,128,1,21,143,TWrex-cause,812931,Mitral valve prolapse is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by Marfan syndrome or an atrial septal defect,prolapse,marfan syndrome
717919229,5/9/2015 17:11:04,1633271253,5/9/2015 17:10:39,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 17:19:41,1633274732,5/9/2015 17:18:46,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 17:21:25,1633275376,5/9/2015 17:19:26,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,179-188-196-207-214,"retarded growth, deafness), NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 17:49:26,1633286095,5/9/2015 17:49:08,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 17:51:11,1633286695,5/9/2015 17:50:30,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 18:04:40,1633291730,5/9/2015 18:03:43,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM, pulmonary artery stenosis, Noonan syndrome, Carney complex, Peutz Jeghers syndrome.",44-52-61-74-95-110-117-132-142-149-207-214-224-231-244-250-258,4-44-52-207-214-224-231-244-250-258-13,"Familial lentiginosis LEOPARD syndrome NOONAN SYNDROME, Carney complex, Peutz Jeghers syndrome.","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 18:06:22,1633292306,5/9/2015 18:05:44,false,instagc,1,24252915,GBR,,,80.44.147.241,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 18:09:41,1633293468,5/9/2015 18:09:25,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 18:09:53,1633293521,5/9/2015 18:09:09,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919229,5/9/2015 18:37:30,1633303510,5/9/2015 18:37:02,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,110,207,,,130,222,OCULAR HYPERTELORISM,NOONAN SYNDROME,"OCULAR HYPERTELORISM,",110-117,207-214,"NOONAN SYNDROME,","33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome.",110 117,207 214,110,207,1,130,222,TWrex-cause,812834,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), Noonan syndrome, Carney complex, and Peutz-Jeghers syndrome",ocular hypertelorism,noonan syndrome
717919230,5/9/2015 18:43:49,1633306146,5/9/2015 18:42:35,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,73,112,,,78,117,FEVER,VIRUS,fulminant yellow FEVER,56-66-73,89-94-99-106-112-93,wild - type yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 18:54:05,1633310306,5/9/2015 18:53:37,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,73,112,,,78,117,FEVER,VIRUS,fulminant yellow FEVER,66-73-56,99-106-112,yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 18:58:02,1633311756,5/9/2015 18:57:26,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,73,112,,,78,117,FEVER,VIRUS,101 Vaccine viscerotropic fulminant yellow FEVER wild - type yellow fever virus.,0-5-56-66-73-89-93-94-99-106-112-24,0-5-24-56-66-73-89-94-99-106-112-93,101 Vaccine viscerotropic fulminant yellow fever wild - type yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 18:58:09,1633311802,5/9/2015 18:57:53,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,73,112,,,78,117,FEVER,VIRUS,fulminant yellow FEVER,56-66-73,89-99-106-112-94,wild type yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 18:59:13,1633312053,5/9/2015 18:59:01,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,73,112,,,78,117,FEVER,VIRUS,fulminant yellow FEVER,56-66-73,94-99-106-112-89,wild type yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 19:15:31,1633322285,5/9/2015 19:15:21,false,clixsense,1,24763049,GBR,,,86.137.164.185,73,112,,,78,117,FEVER,VIRUS,FEVER,73,112,VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 19:17:14,1633324580,5/9/2015 19:16:40,false,neodev,1,32216655,NLD,7,Amsterdam,82.171.230.125,73,112,,,78,117,FEVER,VIRUS,viscerotropic disease resembles fulminant yellow FEVER caused by wild type yellow fever virus.,24-38-46-56-66-73-79-86-89-94-99-106-112,24-38-56-66-73-79-86-89-94-99-106-112-46,viscerotropic disease resembles fulminant yellow fever caused by wild type yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 19:29:00,1633338198,5/9/2015 19:28:46,false,dailyrewardsca,1,32438879,CAN,NL,Mount Pearl,47.54.197.0,73,112,,,78,117,FEVER,VIRUS,FEVER,73,99-106-112,yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 19:37:13,1633341673,5/9/2015 19:36:26,false,instagc,1,22419688,USA,MI,Fenton,96.35.84.102,73,112,,,78,117,FEVER,VIRUS,fulminant yellow FEVER,56-66-73,99-106-112,yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919230,5/9/2015 19:39:59,1633342630,5/9/2015 19:38:35,false,elite,1,30064988,GBR,,,89.241.94.221,73,112,,,78,117,FEVER,VIRUS,fulminant yellow FEVER,56-66-73,99-106-112,yellow fever VIRUS.,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus.,73,112,73,112,1,78,117,TWrex-cause,812503,101  Vaccine-associated viscerotropic disease resembles fulminant yellow fever caused by wild-type yellow fever virus,fever,virus
717919231,5/9/2015 16:27:33,1633254007,5/9/2015 16:27:11,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 16:41:25,1633259201,5/9/2015 16:40:42,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 16:55:14,1633265005,5/9/2015 16:55:01,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 16:56:38,1633265618,5/9/2015 16:56:07,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,NEPHRITIS,195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 17:04:48,1633269043,5/9/2015 17:03:38,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 17:05:13,1633269209,5/9/2015 17:04:30,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 17:08:36,1633270472,5/9/2015 17:06:36,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,46-54-73-82-88,COMPLEX DISEASES SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 17:31:06,1633279079,5/9/2015 17:30:52,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,NEPHRITIS,195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 17:32:59,1633279932,5/9/2015 17:32:40,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,tubulointerstitial NEPHRITIS,176-195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919231,5/9/2015 17:42:19,1633283353,5/9/2015 17:41:19,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,195,73,,,204,101,NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS,NEPHRITIS,195,73-82-88,SYSTEMIC LUPUS ERYTHEMATOSUS,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well.",195,73 82 88,195,73,1,204,101,TWrex-cause,811913,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although systemic lupus erythematosus is commonly associated with glomerular lesions, renal biopsies often show tubulointerstitial nephritis or immune complex deposits along the tubular basement membrane as well",nephritis,systemic lupus erythematosus
717919232,5/9/2015 16:28:39,1633254443,5/9/2015 16:28:27,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 16:45:20,1633260456,5/9/2015 16:44:31,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 16:56:36,1633265599,5/9/2015 16:56:24,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 16:58:48,1633266411,5/9/2015 16:58:26,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 17:06:22,1633269647,5/9/2015 17:06:03,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 17:09:40,1633270886,5/9/2015 17:08:48,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37-48-55-58,OMEPRAZOLE versus H2 receptor,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 17:11:45,1633271389,5/9/2015 17:11:06,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 17:33:26,1633280109,5/9/2015 17:33:16,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 17:34:29,1633280559,5/9/2015 17:34:06,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37,OMEPRAZOLE,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919232,5/9/2015 17:44:19,1633284155,5/9/2015 17:43:43,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,126,37,,,137,47,ESOPHAGITIS,OMEPRAZOLE,ESOPHAGITIS.,126,37-57,OMEPRAZOLE -,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.",126,37,126,37,-1,137,47,TWrex-cause,803811,"Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis",esophagitis,omeprazole
717919233,5/9/2015 20:55:49,1633368682,5/9/2015 20:55:28,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,115-123-128,EPOETIN ALFA Therapy,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/9/2015 21:30:06,1633381127,5/9/2015 21:29:53,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,166,115,,,172,127,ANEMIA,EPOETIN ALFA,Treatment of iron deficiency ANEMIA in adult,137-147-150-155-166-173-176,83-96-105-115-123-128-137,Hemodialysis Patients Receiving EPOETIN ALFA Therapy Treatment,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/9/2015 22:15:10,1633397266,5/9/2015 22:14:49,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,166,115,,,172,127,ANEMIA,EPOETIN ALFA,Hemodialysis iron deficiency ANEMIA,83-150-155-166,83-115-123,Hemodialysis EPOETIN ALFA,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/9/2015 22:44:29,1633409172,5/9/2015 22:44:05,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,115-123,EPOETIN ALFA,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/9/2015 23:50:13,1633437892,5/9/2015 23:49:56,false,neodev,1,31139768,USA,DE,,108.59.10.153,166,115,,,172,127,ANEMIA,EPOETIN ALFA,Treatment of iron deficiency ANEMIA in adult and pediatric hemodialysis,137-147-150-155-166-173-176-186-196-182,83-96-105-115-123-128-137,Hemodialysis Patients Receiving EPOETIN ALFA Therapy Treatment,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/10/2015 00:19:21,1633451464,5/10/2015 00:18:54,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,115-123-128-137,EPOETIN ALFA Therapy Treatment,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/10/2015 00:50:30,1633461869,5/10/2015 00:50:07,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,115-123-128-137,EPOETIN ALFA Therapy Treatment,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/10/2015 01:01:19,1633465421,5/10/2015 01:00:43,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,115-123-128,EPOETIN ALFA Therapy,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/10/2015 01:54:33,1633483454,5/10/2015 01:53:58,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,115-123-128,EPOETIN ALFA Therapy,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919233,5/10/2015 02:00:04,1633485254,5/10/2015 01:59:09,false,clixsense,1,22947672,GBR,,,88.144.86.217,166,115,,,172,127,ANEMIA,EPOETIN ALFA,iron deficiency ANEMIA,150-155-166,83-115-123-128-137,Hemodialysis EPOETIN ALFA Therapy Treatment,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy.",166,115 123,166,115,-1,172,127,TWrex-cause,800108,"1 ,   2 ,   3  Class:  Iron Preparations 20:04.04  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of iron deficiency anemia in adult and pediatric hemodialysis patients receiving epoetin alfa therapy",anemia,epoetin alfa
717919234,5/9/2015 20:54:56,1633368363,5/9/2015 20:54:36,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/9/2015 21:29:15,1633380774,5/9/2015 21:29:01,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,83,46,,,93,54,INFARCTION,ATENOLOL,prevention of myocardial INFARCTION in intermediate coronary syndrome.,58-69-72-83-94-97-110-119,22-28-31-39-46-55-58-69-72-83,Trial of heparin versus ATENOLOL in prevention of myocardial infarction,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/9/2015 22:14:33,1633396991,5/9/2015 22:14:20,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,31-46-72-83,heparin ATENOLOL myocardial infarction,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/9/2015 22:43:43,1633408712,5/9/2015 22:43:22,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/9/2015 23:48:43,1633437105,5/9/2015 23:48:25,false,neodev,1,31139768,USA,DE,,108.59.10.153,83,46,,,93,54,INFARCTION,ATENOLOL,INFARCTION intermediate coronary syndrome.,83-97-110-119,28-31-39-46-55-58-69-72-83,of heparin versus ATENOLOL in prevention of myocardial infarction,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/10/2015 00:18:37,1633451214,5/10/2015 00:18:12,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/10/2015 00:49:37,1633461531,5/10/2015 00:49:17,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/10/2015 00:59:46,1633464907,5/10/2015 00:59:04,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/10/2015 01:53:10,1633482896,5/10/2015 01:52:47,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919234,5/10/2015 01:53:37,1633483085,5/10/2015 01:53:16,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,83,46,,,93,54,INFARCTION,ATENOLOL,myocardial INFARCTION,72-83,46,ATENOLOL,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.",83,46,83,46,-1,93,54,TWrex-cause,805248,"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome",infarction,atenolol
717919235,5/9/2015 20:56:42,1633368919,5/9/2015 20:56:13,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",13-20,55-68,"prescription OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/9/2015 21:30:40,1633381285,5/9/2015 21:30:23,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,20,68,,,25,75,ABUSE,OPIOID,"Rationale: • Opioid ABUSE, including nonmedical use opioids,",0-11-13-20-27-37-48-68,13-48-52-55-68-77-80-82-101-108,"Opioid use of prescription OPIOIDS, is a significant health problem.","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/9/2015 22:15:47,1633397513,5/9/2015 22:15:37,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,20,68,,,25,75,ABUSE,OPIOID,"• Opioid ABUSE,",11-13-20,68,"OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/9/2015 22:45:27,1633409592,5/9/2015 22:45:07,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",13-20,55-68,"prescription OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/9/2015 23:50:51,1633438123,5/9/2015 23:50:34,false,neodev,1,31139768,USA,DE,,108.59.10.153,20,68,,,25,75,ABUSE,OPIOID,"Rationale: Opioid ABUSE, including nonmedical",0-13-20-27-37,55-68-77-80-82-94-108-101,"prescription OPIOIDS, is a significant public health problem.","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/10/2015 00:20:15,1633451789,5/10/2015 00:19:35,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",13-20,55-68,"prescription OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/10/2015 00:51:18,1633462177,5/10/2015 00:50:52,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",13-20,68-55,"prescription OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/10/2015 01:02:26,1633465780,5/10/2015 01:01:42,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",20-13,68,"OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/10/2015 01:55:21,1633483696,5/10/2015 01:54:55,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",20-13,68,"OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919235,5/10/2015 02:01:39,1633485918,5/10/2015 02:00:39,false,clixsense,1,22947672,GBR,,,88.144.86.217,20,68,,,25,75,ABUSE,OPIOID,"Opioid ABUSE,",13-20,37-48-55-68-52,"nonmedical use o<span id=transmark></span>f prescription OPIOIDS,","Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem.",20,68,20,68,1,25,75,TWrex-cause,815137,"Rationale: • Opioid abuse, including nonmedical use of prescription opioids, is a significant public health problem",abuse,opioid
717919236,5/9/2015 16:26:49,1633253748,5/9/2015 16:26:39,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39,TERAZOSIN,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 16:40:02,1633258806,5/9/2015 16:39:22,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 16:54:23,1633264545,5/9/2015 16:54:12,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 16:55:15,1633265029,5/9/2015 16:53:17,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 16:58:24,1633266302,5/9/2015 16:58:11,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 17:03:42,1633268594,5/9/2015 17:03:01,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39,TERAZOSIN,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 17:04:35,1633268996,5/9/2015 17:04:26,false,superrewards,1,31767535,GBR,V2,Glasgow,90.198.84.40,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 17:05:25,1633269262,5/9/2015 17:04:56,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 17:14:34,1633272595,5/9/2015 17:14:25,false,zoombucks,1,4688131,CAN,BC,Vancouver,75.156.91.114,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-49,TERAZOSIN therapy,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919236,5/9/2015 17:19:28,1633274682,5/9/2015 17:18:15,false,quickrewards,1,8672587,USA,TX,El Paso,209.194.208.150,78,39,,,89,48,HYPERPLASIA,TERAZOSIN,benign prostatic HYPERPLASIA.,61-68-78,39-61-68-78,TERAZOSIN benign prostatic hyperplasia.,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.",78,39,78,39,-1,89,48,TWrex-cause,804592,"The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia",hyperplasia,terazosin
717919237,5/9/2015 18:14:04,1633294951,5/9/2015 18:13:44,false,instagc,1,24252915,GBR,,,80.44.147.241,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA prevention,42-50,69-82,ANTIMALARIAL AGENT,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:15:01,1633295376,5/9/2015 18:14:38,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA antimalarial agent doxycycline),42-69-82-99,42-50-69-82-99,malaria prevention ANTIMALARIAL AGENT doxycycline),111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:15:35,1633295611,5/9/2015 18:15:12,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA,42,69-82,ANTIMALARIAL AGENT,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:37:24,1633303425,5/9/2015 18:36:33,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA,42,69-82,ANTIMALARIAL AGENT,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:49:30,1633308788,5/9/2015 18:49:08,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA,42,69-82,ANTIMALARIAL AGENT,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:53:01,1633310048,5/9/2015 18:52:42,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA,42,69-82-88-99,ANTIMALARIAL AGENT (including doxycycline),111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:53:20,1633310146,5/9/2015 18:53:06,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA,42,69-82,ANTIMALARIAL AGENT,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:54:12,1633310334,5/9/2015 18:53:21,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA antimalarial agent doxycycline) malaria.,42-69-99-142-82,42-69-82-99-142,malaria ANTIMALARIAL AGENT doxycycline) malaria.,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 18:54:51,1633310634,5/9/2015 18:54:22,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,the drug for MALARIA prevention that no antimalarial agent,29-33-38-42-50-61-66-69-82,29-33-38-50-61-66-69-82-99-112-123-134-142-42,the drug for malaria prevention that no ANTIMALARIAL AGENT doxycycline) guarantees protection against malaria.,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919237,5/9/2015 19:05:42,1633314160,5/9/2015 19:04:24,false,clixsense,1,16660621,CAN,MB,Winnipeg,24.79.171.172,42,69,,,49,87,MALARIA,ANTIMALARIAL AGENT,MALARIA,42,69-82,ANTIMALARIAL AGENT,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria.,42,69 82,42,69,-1,49,87,TWrex-cause,804443,111 •  Advise patients using the drug for malaria prevention that no antimalarial agent (including doxycycline) guarantees protection against malaria,malaria,antimalarial agent
717919238,5/9/2015 20:07:35,1633351820,5/9/2015 20:07:03,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,"Small bowel OBSTRUCTION caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis postpartum bowel obstruction",145-151-157-169-176-179-187-196-207-223-234-247-257-271-282-288,157-169-176-179-187-196-207-223-234-247-257-282-288,"obstruction caused by CROHN'S DISEASE, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis bowel obstruction","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 20:11:28,1633353284,5/9/2015 20:10:55,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,Small bowel OBSTRUCTION,145-151-157,179-187,"CROHN'S DISEASE,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 20:51:47,1633367226,5/9/2015 20:51:22,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,Small bowel OBSTRUCTION,145-151-157,157-169-176-179-187-196-207-223,"obstruction caused by CROHN'S DISEASE, peritoneal carcinomatosis, sclerosing","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 21:18:49,1633377107,5/9/2015 21:18:33,false,clixsense,1,26492726,GBR,H3,Leeds,2.102.67.197,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,"Small bowel OBSTRUCTION Crohn's disease,",145-151-157-179-187,179-187,"CROHN'S DISEASE,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 21:26:42,1633379930,5/9/2015 21:26:29,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,"Small bowel OBSTRUCTION caused by Crohn's disease,",145-151-157-169-176-179-187,157-169-176-179-187,"obstruction caused by CROHN'S DISEASE,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 22:12:28,1633396244,5/9/2015 22:12:11,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,"OBSTRUCTION Crohn's disease,",157-179-187,179-187-196-207-223-234,"CROHN'S DISEASE, peritoneal carcinomatosis, sclerosing peritonitis,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 22:40:16,1633407125,5/9/2015 22:39:55,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,Small bowel OBSTRUCTION,145-151-157,179-187,"CROHN'S DISEASE,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/9/2015 23:45:04,1633435474,5/9/2015 23:44:25,false,neodev,1,31139768,USA,DE,,108.59.10.153,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,"Small bowel OBSTRUCTION caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis postpartum bowel",145-151-157-169-176-179-187-196-207-223-234-247-257-271-282,157-169-176-179-187-196-207-223-234-145,"Small obstruction caused by CROHN'S DISEASE, peritoneal carcinomatosis, sclerosing peritonitis,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/10/2015 00:14:18,1633449152,5/10/2015 00:13:20,false,prodege,1,27166596,USA,FL,Pompano Beach,68.177.119.2,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,"OBSTRUCTION Crohn's disease,",157-179-187,179-187-196-207-223,"CROHN'S DISEASE, peritoneal carcinomatosis, sclerosing","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919238,5/10/2015 00:15:19,1633449556,5/10/2015 00:13:53,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,157,179,,,168,194,OBSTRUCTION,CROHN'S DISEASE,Small bowel OBSTRUCTION,145-151-157,145-157-169-176-179-187-151,"Small bowel obstruction caused by CROHN'S DISEASE,","Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery.",157,179 187,157,179,1,168,194,TWrex-cause,813405,"Individuals who have bowel resection or lysis of adhesions usually stay in the hospital a few more days until they are able to eat and walk.[4]  Small bowel obstruction caused by Crohn's disease, peritoneal carcinomatosis, sclerosing peritonitis, radiation enteritis and postpartum bowel obstruction are typically treated conservatively, i.e. without surgery",obstruction,crohn's disease
717919239,5/9/2015 16:19:56,1633251045,5/9/2015 16:19:46,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:25:33,1633253234,5/9/2015 16:25:16,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:30:11,1633255019,5/9/2015 16:29:55,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:36:14,1633257320,5/9/2015 16:35:50,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:51:17,1633262626,5/9/2015 16:50:48,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:52:47,1633263546,5/9/2015 16:52:31,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:53:26,1633263915,5/9/2015 16:52:56,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA discontinue,8-41,81-92-100-110-117,"parenteral calcium chloride, SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:56:47,1633265658,5/9/2015 16:56:05,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,"256 If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and or oral or parenteral glucose with a rapid acting insulin preparation.",0-5-8-21-29-41-53-57-63-66-76-81-92-100-110-117-130-134-137-142-145-156-164-169-171-177-184-192,0-5-8-21-29-41-53-57-63-66-76-81-92-100-110-117-130-134-137-142-145-156-164-169-171-177-184-192,"256 If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE, and or oral or parenteral glucose with a rapid acting insulin preparation.","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 16:59:56,1633266911,5/9/2015 16:59:00,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,HYPERKALEMIA,8,110-117,"SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919239,5/9/2015 17:01:03,1633267362,5/9/2015 17:00:37,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,8,110,,,20,128,HYPERKALEMIA,SODIUM BICARBONATE,"HYPERKALEMIA occurs,",8-21,81-92-100-110-117,"parenteral calcium chloride, SODIUM BICARBONATE,","256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation.",8,110 117,8,110,-1,20,128,TWrex-cause,803737,"256  If hyperkalemia occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, sodium bicarbonate, and/or oral or parenteral glucose with a rapid acting insulin preparation",hyperkalemia,sodium bicarbonate
717919240,5/9/2015 17:51:49,1633287125,5/9/2015 17:51:35,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,LYMPHADENOPATHY,9,46-57-87,"INFECTIOUS MONONUCLEOSIS, cytomegalovirus,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 17:55:58,1633288713,5/9/2015 17:55:40,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,LYMPHADENOPATHY,9,46-57,"INFECTIOUS MONONUCLEOSIS,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:09:06,1633293279,5/9/2015 18:08:45,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,"LYMPHADENOPATHY infectious mononucleosis, toxoplasmosis, cytomegalovirus, leukemia.",9-46-57-72-87-107,9-46-57-72-87-107,"lymphadenopathy INFECTIOUS MONONUCLEOSIS, toxoplasmosis, cytomegalovirus, leukemia.","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:10:16,1633293649,5/9/2015 18:09:55,false,instagc,1,24252915,GBR,,,80.44.147.241,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,LYMPHADENOPATHY,9,46-57,"INFECTIOUS MONONUCLEOSIS,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:12:23,1633294317,5/9/2015 18:12:12,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,LYMPHADENOPATHY,9,46-57,"INFECTIOUS MONONUCLEOSIS,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:23:39,1633298659,5/9/2015 18:21:48,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,Painless LYMPHADENOPATHY,0-9,46-57-72,"INFECTIOUS MONONUCLEOSIS, toxoplasmosis,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:42:00,1633305347,5/9/2015 18:41:12,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,LYMPHADENOPATHY,9,46-57,"INFECTIOUS MONONUCLEOSIS,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:44:01,1633306248,5/9/2015 18:43:51,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,Painless LYMPHADENOPATHY,0-9,46-57,"INFECTIOUS MONONUCLEOSIS,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:46:55,1633307714,5/9/2015 18:46:38,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,Painless LYMPHADENOPATHY,0-9,46-57-72-87,"INFECTIOUS MONONUCLEOSIS, toxoplasmosis, cytomegalovirus,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919240,5/9/2015 18:49:06,1633308599,5/9/2015 18:46:25,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,9,46,,,24,70,LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,LYMPHADENOPATHY,9,46-57,"INFECTIOUS MONONUCLEOSIS,","Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia.",9,46 57,9,46,1,24,70,TWrex-cause,814049,"Painless lymphadenopathy can also result from infectious mononucleosis, toxoplasmosis, cytomegalovirus, or leukemia",lymphadenopathy,infectious mononucleosis
717919241,5/9/2015 16:19:45,1633250976,5/9/2015 16:19:33,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,40,23,,,51,28,NEPHROPATHY,VIRUS,virus associated NEPHROPATHY:,23-29-40,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:25:16,1633253101,5/9/2015 16:24:54,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,40,23,,,51,28,NEPHROPATHY,VIRUS,Human immunodeficiency virus associated NEPHROPATHY:,6-23-29-40-0,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:29:54,1633254913,5/9/2015 16:29:41,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,40,23,,,51,28,NEPHROPATHY,VIRUS,NEPHROPATHY:,40,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:35:48,1633257111,5/9/2015 16:34:42,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,40,23,,,51,28,NEPHROPATHY,VIRUS,NEPHROPATHY:,40,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:50:47,1633262407,5/9/2015 16:49:48,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,40,23,,,51,28,NEPHROPATHY,VIRUS,Human immunodeficiency virus associated NEPHROPATHY:,0-6-23-40-29,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:52:30,1633263293,5/9/2015 16:52:06,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,40,23,,,51,28,NEPHROPATHY,VIRUS,Human immunodeficiency virus - associated NEPHROPATHY:,0-6-23-28-29-40,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:52:55,1633263598,5/9/2015 16:52:42,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,40,23,,,51,28,NEPHROPATHY,VIRUS,immunodeficiency virus associated NEPHROPATHY: a primary care,6-23-29-40-53-55-63,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:56:04,1633265357,5/9/2015 16:55:44,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,40,23,,,51,28,NEPHROPATHY,VIRUS,Human immunodeficiency virus associated NEPHROPATHY: a primary care perspective.,6-23-29-40-53-55-63-68-0,0-6-23-29-40-53-55-63-68,Human immunodeficiency VIRUS associated nephropathy: a primary care perspective.,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 16:58:57,1633266437,5/9/2015 16:58:33,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,40,23,,,51,28,NEPHROPATHY,VIRUS,immunodeficiency virus associated NEPHROPATHY:,6-23-29-40,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919241,5/9/2015 17:00:36,1633267132,5/9/2015 17:00:16,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,40,23,,,51,28,NEPHROPATHY,VIRUS,immunodeficiency virus associated NEPHROPATHY:,6-23-29-40,0-6-23-29-40,Human immunodeficiency VIRUS associated nephropathy:,Human immunodeficiency virus-associated nephropathy: a primary care perspective.,40,23,40,23,1,51,28,TWrex-cause,812357,Human immunodeficiency virus-associated nephropathy: a primary care perspective,nephropathy,virus
717919242,5/9/2015 16:28:26,1633254364,5/9/2015 16:28:15,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,56,0,,,62,10,ANGINA,ENOXAPARIN,unstable ANGINA,47-56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 16:44:29,1633260216,5/9/2015 16:43:50,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,56,0,,,62,10,ANGINA,ENOXAPARIN,unstable ANGINA,47-56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 16:56:22,1633265519,5/9/2015 16:55:56,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,56,0,,,62,10,ANGINA,ENOXAPARIN,unstable ANGINA,47-56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 16:58:25,1633266304,5/9/2015 16:58:00,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,56,0,,,62,10,ANGINA,ENOXAPARIN,ANGINA,56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 17:06:02,1633269557,5/9/2015 17:05:35,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,56,0,,,62,10,ANGINA,ENOXAPARIN,ANGINA,56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 17:08:45,1633270511,5/9/2015 17:07:54,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,56,0,,,62,10,ANGINA,ENOXAPARIN,ANGINA,56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 17:11:05,1633271252,5/9/2015 17:10:55,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,56,0,,,62,10,ANGINA,ENOXAPARIN,events in unstable ANGINA,37-44-47-56,0-11,ENOXAPARIN reduced,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 17:33:14,1633280031,5/9/2015 17:32:28,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,56,0,,,62,10,ANGINA,ENOXAPARIN,ANGINA,56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 17:34:05,1633280335,5/9/2015 17:33:44,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,56,0,,,62,10,ANGINA,ENOXAPARIN,unstable ANGINA,47-56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919242,5/9/2015 17:44:12,1633284124,5/9/2015 17:43:22,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,56,0,,,62,10,ANGINA,ENOXAPARIN,ANGINA,56,0,ENOXAPARIN,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days.,56,0,56,0,-1,62,10,TWrex-cause,800231,Enoxaparin reduced combined coronary events in unstable angina and non-Q-wave MI at 14 and 30 days,angina,enoxaparin
717919243,5/9/2015 16:12:15,1633248119,5/9/2015 16:12:09,false,clixsense,1,6352682,GBR,H9,London,2.125.111.168,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,treatment of CNS HISTOPLASMOSIS in HIV infected,42-52-55-59-74-77-81,0-4-8-13-26-28-38-42,"440 , 441 AMPHOTERICIN B liposomal for treatment","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:17:37,1633250213,5/9/2015 16:17:17,false,gifthunterclub,1,30901412,GBR,G5,Margate,85.210.119.8,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,treatment of CNS HISTOPLASMOSIS in HIV infected,42-52-55-59-74-77-81,4-8-13-26-28-38-42-81,", 441 AMPHOTERICIN B liposomal for treatment infected","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:18:47,1633250650,5/9/2015 16:18:28,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,4-13-26,", AMPHOTERICIN B","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:23:47,1633252323,5/9/2015 16:23:32,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,13-26-28,AMPHOTERICIN B liposomal,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:28:52,1633254524,5/9/2015 16:28:40,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,4-13-26,", AMPHOTERICIN B","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:31:12,1633255461,5/9/2015 16:29:58,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,13-26-28,AMPHOTERICIN B liposomal,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:33:47,1633256287,5/9/2015 16:33:18,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,13-26-28,AMPHOTERICIN B liposomal,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:47:49,1633261344,5/9/2015 16:46:13,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,4-13-26-28,", AMPHOTERICIN B liposomal","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:50:40,1633262363,5/9/2015 16:50:25,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,CNS HISTOPLASMOSIS,55-59,4-13-26-28,", AMPHOTERICIN B liposomal","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919243,5/9/2015 16:50:53,1633262427,5/9/2015 16:50:43,false,neodev,1,31789301,USA,OH,Columbus,216.185.58.182,59,13,,,73,27,HISTOPLASMOSIS,AMPHOTERICIN B,treatment of CNS HISTOPLASMOSIS in HIV infected,42-52-55-59-74-77-81,0-4-8-13-26-28-38-42,"440 , 441 AMPHOTERICIN B liposomal for treatment","440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable.",59,13 26,59,13,-1,73,27,TWrex-cause,800098,"440 ,   441  Amphotericin B liposomal for treatment of CNS histoplasmosis in HIV-infected infants, children, or adolescents: CDC, NIH, and IDSA recommend initial regimen of 5 mg/kg once daily for 4-6 weeks and follow-up treatment with oral itraconazole for a total treatment duration of at least 12 months and until abnormal CSF findings resolve and histoplasmal antigen is undetectable",histoplasmosis,amphotericin b
717919244,5/9/2015 20:54:03,1633368071,5/9/2015 20:53:38,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,62,0-13,Burkholderia PSEUDOMALLEI,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/9/2015 21:28:43,1633380615,5/9/2015 21:28:29,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,disease known as MELIOIDOSIS,45-53-59-62,0-13-27-34-45-62,Burkholderia PSEUDOMALLEI causes a disease melioidosis,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/9/2015 22:14:07,1633396847,5/9/2015 22:13:51,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,62,0-13,Burkholderia PSEUDOMALLEI,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/9/2015 22:43:08,1633408471,5/9/2015 22:42:53,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,62,0-13,Burkholderia PSEUDOMALLEI,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/9/2015 23:47:57,1633436745,5/9/2015 23:47:34,false,neodev,1,31139768,USA,DE,,108.59.10.153,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,disease known as MELIOIDOSIS that is mostly Asian tropics,45-53-59-62-74-79-82-104-110,0-13-27-34-36-45,Burkholderia PSEUDOMALLEI causes a distinct disease,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/10/2015 00:17:55,1633450859,5/10/2015 00:17:41,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,62,13-0,Burkholderia PSEUDOMALLEI,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/10/2015 00:49:00,1633461305,5/10/2015 00:48:29,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,62,0-13,Burkholderia PSEUDOMALLEI,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/10/2015 00:57:50,1633464416,5/10/2015 00:55:25,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,Burkholderia pseudomallei causes a distinct disease known as MELIOIDOSIS that is mostly limited to the Asian tropics,0-13-27-34-36-45-53-59-62-74-79-82-89-97-100-104-110,0-13-27-34-36-45-53-59-62-74-79-82-89-97-100-104-110,Burkholderia PSEUDOMALLEI causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/10/2015 01:00:28,1633465115,5/10/2015 01:00:17,false,elite,1,31848723,USA,,,155.94.185.225,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,disease known as MELIOIDOSIS that is mostly,45-53-59-62-74-79-82,0-13-27-34-36,Burkholderia PSEUDOMALLEI causes a distinct,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919244,5/10/2015 01:52:29,1633482705,5/10/2015 01:52:16,false,neodev,1,31650069,CAN,BC,Kelowna,154.20.181.121,62,13,,,73,25,MELIOIDOSIS,PSEUDOMALLEUS,MELIOIDOSIS,62,0-13,Burkholderia PSEUDOMALLEI,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis.,62,13,62,13,1,73,25,TWrex-cause,812253,Burkholderia pseudomallei  causes a distinct disease known as melioidosis that is mostly limited to the Asian tropics (see  Melioidosis,melioidosis,pseudomalleus
717919245,5/9/2015 17:22:27,1633275757,5/9/2015 17:21:54,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,88,128,,,93,132,LUPUS,DRUG,"LUPUS syndrome,",88-94,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 17:24:09,1633276451,5/9/2015 17:23:31,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,88,128,,,93,132,LUPUS,DRUG,"LUPUS syndrome,",88-94,110-119-124-128-133-136,resolves when the DRUG is stopped.,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 17:50:29,1633286482,5/9/2015 17:50:15,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,88,128,,,93,132,LUPUS,DRUG,LUPUS,88,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 17:53:15,1633287705,5/9/2015 17:52:32,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,88,128,,,93,132,LUPUS,DRUG,"- LUPUS syndrome,",79-88-94,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 18:06:42,1633292429,5/9/2015 18:06:15,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,88,128,,,93,132,LUPUS,DRUG,"hydralazine LUPUS syndrome,",36-88-94,36-88-94-128,"hydralazine lupus syndrome, DRUG","Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 18:07:39,1633292734,5/9/2015 18:07:13,false,instagc,1,24252915,GBR,,,80.44.147.241,88,128,,,93,132,LUPUS,DRUG,"drug - induced LUPUS syndrome,",75-79-80-88-94,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 18:10:27,1633293679,5/9/2015 18:10:14,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,88,128,,,93,132,LUPUS,DRUG,"LUPUS syndrome,",88-94,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 18:16:21,1633295849,5/9/2015 18:13:54,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,88,128,,,93,132,LUPUS,DRUG,"drug induced LUPUS syndrome,",75-80-88-94,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 18:38:57,1633303935,5/9/2015 18:38:13,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,88,128,,,93,132,LUPUS,DRUG,"LUPUS syndrome,",88-94,128,DRUG,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919245,5/9/2015 18:41:42,1633305232,5/9/2015 18:41:06,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,88,128,,,93,132,LUPUS,DRUG,hydralazine LUPUS,36-88,88-94-128,"lupus syndrome, DRUG","Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped.",88,128,88,128,1,93,132,TWrex-cause,811911,"Long-term, high-dose (> 300 mg/day) hydralazine has been associated with a drug-induced lupus syndrome, which resolves when the drug is stopped",lupus,drug
717919246,5/9/2015 17:55:04,1633288341,5/9/2015 17:54:40,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,120,66,,,124,76,AIDS,ZIDOVUDINE,AIDS associated Kaposi's sarcoma (AIDS KS):,86-102-111-119-125-91,66-77,ZIDOVUDINE (ZDV),"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:13:21,1633294672,5/9/2015 18:12:55,false,instagc,1,24252915,GBR,,,80.44.147.241,120,66,,,124,76,AIDS,ZIDOVUDINE,(AIDS,119,66,ZIDOVUDINE,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:14:08,1633294982,5/9/2015 18:13:35,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,120,66,,,124,76,AIDS,ZIDOVUDINE,Interferon α zidovudine AIDS Kaposi's sarcoma (AIDS KS):,40-51-66-86-102-111-119-125,40-51-53-58-61-66-83-86-102-111,Interferon α (IFN α) plus ZIDOVUDINE in AIDS Kaposi's sarcoma,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:14:55,1633295358,5/9/2015 18:14:38,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,120,66,,,124,76,AIDS,ZIDOVUDINE,Kaposi's sarcoma,102-111,66,ZIDOVUDINE,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:34:54,1633302473,5/9/2015 18:33:24,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,120,66,,,124,76,AIDS,ZIDOVUDINE,AIDS associated Kaposi's sarcoma (AIDS KS):,86-91-102-111-119-125,66-77,ZIDOVUDINE (ZDV),"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:48:26,1633308319,5/9/2015 18:48:01,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,120,66,,,124,76,AIDS,ZIDOVUDINE,Kaposi's sarcoma,102-111,66,ZIDOVUDINE,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:52:17,1633309804,5/9/2015 18:51:35,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,120,66,,,124,76,AIDS,ZIDOVUDINE,Interferon - α (IFN - α) plus zidovudine (ZDV) AIDS associated Kaposi's sarcoma (AIDS KS): phase I,40-50-51-53-57-58-61-66-77-86-91-102-111-119-125-141-147,40-50-51-53-57-58-61-66-77-83-86-91-102-111-119-125-141-147,Interferon - α (IFN - α) plus ZIDOVUDINE (ZDV) in AIDS associated Kaposi's sarcoma (AIDS KS): phase I,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:52:27,1633309844,5/9/2015 18:52:10,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,120,66,,,124,76,AIDS,ZIDOVUDINE,Kaposi's sarcoma (AIDS KS):,102-111-119-125,40-51-53-58-61-66-83-86-77,Interferon α (IFN α) plus ZIDOVUDINE (ZDV) in AIDS,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:52:50,1633309978,5/9/2015 18:52:33,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,120,66,,,124,76,AIDS,ZIDOVUDINE,Kaposi's sarcoma (AIDS KS):,102-111-119-125,66-77,ZIDOVUDINE (ZDV),"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919246,5/9/2015 18:53:25,1633310157,5/9/2015 18:52:20,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,120,66,,,124,76,AIDS,ZIDOVUDINE,Kaposi's sarcoma (AIDS KS): an ongoing phase I trial.,102-111-119-125-130-133-141-149-147,40-51-53-58-61-66-83-86-91-102-111-130-133-141-149-147,Interferon α (IFN α) plus ZIDOVUDINE in AIDS associated Kaposi's sarcoma an ongoing phase I trial.,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial.",,66,120,66,-1,124,76,TWrex-cause,800210,"Krown SE, Bundow B, Gansbacher W et al. Interferon-α (IFN-α) plus zidovudine (ZDV) in AIDS-associated Kaposi's sarcoma (AIDS/KS): an ongoing phase I trial",AIDS,zidovudine
717919247,5/9/2015 17:52:09,1633287225,5/9/2015 17:51:50,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 17:56:39,1633288963,5/9/2015 17:55:59,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:09:51,1633293519,5/9/2015 18:09:07,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,"vancomycin, rifampin, ceftriaxone cefotaxime PNEUMOCOCCAL MENINGITIS cephalosporin",26-38-59-74-106-119-180,0-8-13-26-38-59-74-106-119-180,"*Triple drug therapy VANCOMYCIN, rifampin, ceftriaxone cefotaxime pneumococcal meningitis cephalosporin","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:10:41,1633293717,5/9/2015 18:10:18,false,instagc,1,24252915,GBR,,,80.44.147.241,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:12:41,1633294421,5/9/2015 18:12:24,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:24:24,1633298932,5/9/2015 18:23:46,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:42:45,1633305635,5/9/2015 18:42:01,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:44:16,1633306330,5/9/2015 18:44:02,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,26,"VANCOMYCIN,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:47:12,1633307844,5/9/2015 18:46:56,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,PNEUMOCOCCAL MENINGITIS,106-119,8-13-26-38,"drug therapy VANCOMYCIN, rifampin,","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919247,5/9/2015 18:49:05,1633308619,5/9/2015 18:48:03,false,neodev,1,31706957,NLD,7,Amsterdam,145.100.72.165,106,26,,,129,36,PNEUMOCOCCAL MENINGITIS,VANCOMYCIN,cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS,74-85-89-92-102-106-119,0-8-13-21-26-38-48-52-59-85-89-92-102-106-119,"*Triple drug therapy with VANCOMYCIN, rifampin, and either ceftriaxone may be necessary for pneumococcal meningitis","*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",106 119,26,106,26,-1,129,36,TWrex-cause,805206,"*Triple-drug therapy with vancomycin, rifampin, and either ceftriaxone or cefotaxime may be necessary for pneumococcal meningitis if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL",pneumococcal meningitis,vancomycin
717919248,5/9/2015 16:53:41,1633264064,5/9/2015 16:53:04,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 17:04:58,1633269088,5/9/2015 17:04:20,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 17:10:38,1633271125,5/9/2015 17:10:22,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 17:18:43,1633274410,5/9/2015 17:17:44,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX, caused by B. anthracis,",0-9-16-19-22,0-9-16-19-22,"Anthrax, caused by B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 17:19:24,1633274623,5/9/2015 17:18:58,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,0-9-16-19-22,"Anthrax, caused by B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 17:49:07,1633285973,5/9/2015 17:48:51,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 17:50:29,1633286480,5/9/2015 17:50:13,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 18:03:42,1633291312,5/9/2015 18:03:00,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX, caused B. anthracis, bioterrorism weapon",0-9-19-22-74-87,0-19-22-64-74-87,"Anthrax, B. ANTHRACIS, potential bioterrorism weapon","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 18:05:42,1633292084,5/9/2015 18:05:21,false,instagc,1,24252915,GBR,,,80.44.147.241,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919248,5/9/2015 18:09:24,1633293398,5/9/2015 18:09:02,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,0,19,,,7,31,ANTHRAX,B. ANTHRACIS,"ANTHRAX,",0,19-22,"B. ANTHRACIS,","Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks.",0,19 22,0,19,1,7,31,TWrex-cause,811593,"Anthrax, caused by B. anthracis, has gained new importance as a potential bioterrorism weapon after the 2001 attacks",anthrax,B. anthracis
717919249,5/9/2015 17:51:20,1633286784,5/9/2015 17:51:05,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84,MS,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 17:55:05,1633288342,5/9/2015 17:54:34,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84-87-95,"MS related symptoms,","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:08:19,1633293007,5/9/2015 18:07:52,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,115,84,,,125,86,SPASTICITY,MS,"marijuana MS SPASTICITY, pain, and tremor.",84-115-127-133-137-39,39-84-87-95-115-127-137,"marijuana MS related symptoms, spasticity, pain, tremor.","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:09:07,1633293284,5/9/2015 18:08:44,false,instagc,1,24252915,GBR,,,80.44.147.241,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84-87-95,"MS related symptoms,","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:11:39,1633294065,5/9/2015 18:11:27,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84-87-95,"MS related symptoms,","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:20:43,1633297506,5/9/2015 18:18:50,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84-87-95,"MS related symptoms,","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:40:30,1633304572,5/9/2015 18:39:58,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84,MS,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:43:05,1633305778,5/9/2015 18:42:35,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,115,84,,,125,86,SPASTICITY,MS,"symptoms, SPASTICITY,",115-95,84-87-95,"MS related symptoms,","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:43:37,1633306083,5/9/2015 18:43:23,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,115,84,,,125,86,SPASTICITY,MS,"SPASTICITY,",115,84,MS,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919249,5/9/2015 18:46:37,1633307564,5/9/2015 18:45:53,false,tremorgames,1,28868712,CAN,BC,Trail,173.180.72.151,115,84,,,125,86,SPASTICITY,MS,"symptoms, SPASTICITY, pain, tremor.",95-115-127-137,84-95,"MS symptoms,","COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor.",115,84,115,84,1,125,86,TWrex-cause,813120,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS-related symptoms, including spasticity, pain, and tremor",spasticity,MS
717919250,5/9/2015 16:26:38,1633253659,5/9/2015 16:26:24,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14-26,LEGIONELLA infection,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 16:39:21,1633258607,5/9/2015 16:38:55,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14-26,LEGIONELLA infection,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 16:53:16,1633263788,5/9/2015 16:52:48,false,clixsense,1,6338946,CAN,QC,Montréal,209.197.170.96,53,14,,,60,24,DISEASE,LEGIONELLA,DISEASE.,53,14,LEGIONELLA,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 16:54:11,1633264439,5/9/2015 16:54:00,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14-26,LEGIONELLA infection,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 16:58:10,1633266212,5/9/2015 16:57:55,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14-36,LEGIONELLA in,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 16:58:34,1633266349,5/9/2015 16:58:25,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,53,14,,,60,24,DISEASE,LEGIONELLA,Diagnosis of Legionella infection in Legionnaires' DISEASE.,0-10-26-36-39-53-14,0-10-14-26-36-39-53,Diagnosis of LEGIONELLA infection in Legionnaires' disease.,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 17:02:58,1633268339,5/9/2015 17:02:17,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14,LEGIONELLA,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 17:04:25,1633268909,5/9/2015 17:04:14,false,superrewards,1,31767535,GBR,V2,Glasgow,90.198.84.40,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14-26,LEGIONELLA infection,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 17:04:55,1633269085,5/9/2015 17:04:06,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,53,14,,,60,24,DISEASE,LEGIONELLA,infection in Legionnaires' DISEASE.,26-36-39-53,0-10-14,Diagnosis of LEGIONELLA,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919250,5/9/2015 17:14:24,1633272522,5/9/2015 17:14:03,false,zoombucks,1,4688131,CAN,BC,Vancouver,75.156.91.114,53,14,,,60,24,DISEASE,LEGIONELLA,Legionnaires' DISEASE.,39-53,14,LEGIONELLA,Diagnosis of  Legionella  infection in Legionnaires' disease.,53,14,53,14,1,60,24,TWrex-cause,812009,Diagnosis of  Legionella  infection in Legionnaires' disease,disease,legionella
717919251,5/9/2015 20:55:24,1633368579,5/9/2015 20:55:00,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32,"PRAZOSIN,","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/9/2015 21:29:52,1633381009,5/9/2015 21:29:15,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,108,32,,,120,40,HYPERTENSION,PRAZOSIN,Postsynaptic primary treatment of HYPERTENSION,0-87-95-105-108,27-32-42-53-64-68-71-78-83-95-108-105,"(eg, PRAZOSIN, terazosin, doxazosin) are no longer used for treatment of hypertension","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/9/2015 22:14:48,1633397109,5/9/2015 22:14:34,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32-42-53-108,"PRAZOSIN, terazosin, doxazosin) hypertension","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/9/2015 22:44:04,1633408880,5/9/2015 22:43:45,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32,"PRAZOSIN,","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/9/2015 23:49:52,1633437647,5/9/2015 23:48:46,false,neodev,1,31139768,USA,DE,,108.59.10.153,108,32,,,120,40,HYPERTENSION,PRAZOSIN,primary treatment of HYPERTENSION,87-95-105-108,32-42-53,"PRAZOSIN, terazosin, doxazosin)","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/10/2015 00:18:53,1633451317,5/10/2015 00:18:38,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32,"PRAZOSIN,","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/10/2015 00:50:05,1633461666,5/10/2015 00:49:38,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32,"PRAZOSIN,","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/10/2015 01:00:42,1633465178,5/10/2015 00:59:47,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32,"PRAZOSIN,","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/10/2015 01:53:57,1633483200,5/10/2015 01:53:38,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,108,32,,,120,40,HYPERTENSION,PRAZOSIN,HYPERTENSION,108,32,"PRAZOSIN,","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919251,5/10/2015 01:59:07,1633484884,5/10/2015 01:58:18,false,clixsense,1,22947672,GBR,,,88.144.86.217,108,32,,,120,40,HYPERTENSION,PRAZOSIN,treatment of HYPERTENSION,95-105-108,15-18-27-32-42-53,"1 blockers (eg, PRAZOSIN, terazosin, doxazosin)","Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit.",108,32,108,32,-1,120,40,TWrex-cause,803785,"Postsynaptic α 1 -blockers (eg, prazosin, terazosin, doxazosin) are no longer used for primary treatment of hypertension because evidence suggests no mortality benefit",hypertension,prazosin
717919252,5/9/2015 17:51:34,1633286933,5/9/2015 17:51:21,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID,29,50,HAEMOPHILUS,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 17:55:40,1633288566,5/9/2015 17:55:06,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID,29,50-62,HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:08:44,1633293175,5/9/2015 18:08:20,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,29,50,,,38,61,CHANCROID,HAEMOPHILUS,Chancroid CHANCROID Haemophilus ducreyi.,5-29-50-62,5-16-29-50-62,Chancroid Treatment chancroid HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:09:54,1633293529,5/9/2015 18:09:08,false,instagc,1,24252915,GBR,,,80.44.147.241,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID,29,50-62,HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:12:10,1633294223,5/9/2015 18:11:41,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID,29,50-62,HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:21:41,1633297940,5/9/2015 18:20:48,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID caused by Haemophilus ducreyi.,29-39-46-50-62,50-62,HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:40:53,1633304744,5/9/2015 18:40:31,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID,29,50-62,HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:43:12,1633305810,5/9/2015 18:43:06,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,29,50,,,38,61,CHANCROID,HAEMOPHILUS,Chancroid Treatment of CHANCROID caused by Haemophilus,5-16-26-29-39-46-50,29-39-46-50-62,chancroid caused by HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:43:50,1633306158,5/9/2015 18:43:38,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,29,50,,,38,61,CHANCROID,HAEMOPHILUS,CHANCROID,29,50-62,HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
717919252,5/9/2015 18:46:29,1633307544,5/9/2015 18:46:24,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,29,50,,,38,61,CHANCROID,HAEMOPHILUS,Chancroid Treatment of CHANCROID caused by Haemophilus,5-16-26-29-39-46-50,29-39-46-50-62,chancroid caused by HAEMOPHILUS ducreyi.,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi.,29,50,29,50,1,38,61,TWrex-cause,810551,137  Chancroid  Treatment of chancroid caused by  Haemophilus ducreyi,chancroid,haemophilus
